Version: 2017-09-28
Format: classname (Label) [#subclasses][accuracy]

1. [NCIT:C2852](markdown/NCIT_C2852.md) (Adenocarcinoma) [573][67.81%]
1. [NCIT:C2862](markdown/NCIT_C2862.md) (Primary Myelofibrosis) [2][55.21%]
1. [NCIT:C2895](markdown/NCIT_C2895.md) (Benign Ovarian Neoplasm) [30][54.17%]
1. [NCIT:C2896](markdown/NCIT_C2896.md) (Benign Skin Neoplasm) [79][56.25%]
1. [NCIT:C2912](markdown/NCIT_C2912.md) (Burkitt Lymphoma) [33][53.73%]
1. [NCIT:C2915](markdown/NCIT_C2915.md) (Carcinoid Tumor) [42][55.46%]
1. [NCIT:C2916](markdown/NCIT_C2916.md) (Carcinoma) [1857][73.54%]
1. [NCIT:C2917](markdown/NCIT_C2917.md) (Carcinoma In Situ) [95][55.52%]
1. [NCIT:C2920](markdown/NCIT_C2920.md) (Malignant Skin Neoplasm) [211][61.62%]
1. [NCIT:C2921](markdown/NCIT_C2921.md) (Skin Basal Cell Carcinoma) [26][54.17%]
1. [NCIT:C2924](markdown/NCIT_C2924.md) (Ductal Breast Carcinoma In Situ) [3][62.05%]
1. [NCIT:C2926](markdown/NCIT_C2926.md) (Non-Small Cell Lung Carcinoma) [61][56.95%]
1. [NCIT:C2927](markdown/NCIT_C2927.md) (Papillary Carcinoma) [73][57.55%]
1. [NCIT:C2942](markdown/NCIT_C2942.md) (Bile Duct Adenoma) [4][58.33%]
1. [NCIT:C2946](markdown/NCIT_C2946.md) (Chondrosarcoma) [20][55.52%]
1. [NCIT:C2947](markdown/NCIT_C2947.md) (Chordoma) [4][53.45%]
1. [NCIT:C2948](markdown/NCIT_C2948.md) (Choriocarcinoma) [14][62.50%]
1. [NCIT:C2955](markdown/NCIT_C2955.md) (Colorectal Carcinoma) [123][55.64%]
1. [NCIT:C2970](markdown/NCIT_C2970.md) (Adenoid Cystic Carcinoma) [27][57.50%]
1. [NCIT:C2972](markdown/NCIT_C2972.md) (Cystadenoma) [26][53.99%]
1. [NCIT:C2977](markdown/NCIT_C2977.md) (Phyllodes Tumor) [11][53.04%]
1. [NCIT:C2996](markdown/NCIT_C2996.md) (Dysgerminoma) [5][55.00%]
1. [NCIT:C3011](markdown/NCIT_C3011.md) (Yolk Sac Tumor) [13][54.55%]
1. [NCIT:C3017](markdown/NCIT_C3017.md) (Ependymoma) [14][53.90%]
1. [NCIT:C3041](markdown/NCIT_C3041.md) (Fibroma) [24][54.53%]
1. [NCIT:C3042](markdown/NCIT_C3042.md) (Fibromatosis) [9][53.64%]
1. [NCIT:C3049](markdown/NCIT_C3049.md) (Ganglioneuroma) [6][58.33%]
1. [NCIT:C3050](markdown/NCIT_C3050.md) (Gastrin-Producing Neuroendocrine Tumor) [4][58.33%]
1. [NCIT:C3055](markdown/NCIT_C3055.md) (Giant Cell Tumor) [11][54.88%]
1. [NCIT:C3056](markdown/NCIT_C3056.md) (Angiofollicular Lymphoid Hyperplasia) [3][57.14%]
1. [NCIT:C3058](markdown/NCIT_C3058.md) (Glioblastoma) [35][55.70%]
1. [NCIT:C3059](markdown/NCIT_C3059.md) (Glioma) [216][60.55%]
1. [NCIT:C3062](markdown/NCIT_C3062.md) (Pancreatic Glucagon-Producing Neuroendocrine Tumor) [2][56.25%]
1. [NCIT:C3088](markdown/NCIT_C3088.md) (Angiosarcoma) [35][54.31%]
1. [NCIT:C3099](markdown/NCIT_C3099.md) (Hepatocellular Carcinoma) [35][56.14%]
1. [NCIT:C3107](markdown/NCIT_C3107.md) (Langerhans Cell Histiocytosis) [10][54.23%]
1. [NCIT:C3157](markdown/NCIT_C3157.md) (Leiomyoma) [50][54.31%]
1. [NCIT:C3158](markdown/NCIT_C3158.md) (Leiomyosarcoma) [51][55.46%]
1. [NCIT:C3161](markdown/NCIT_C3161.md) (Leukemia) [208][65.92%]
1. [NCIT:C3164](markdown/NCIT_C3164.md) (Acute Basophilic Leukemia) [2][56.25%]
1. [NCIT:C3167](markdown/NCIT_C3167.md) (Acute Lymphoblastic Leukemia) [36][55.64%]
1. [NCIT:C3170](markdown/NCIT_C3170.md) (Acute Megakaryoblastic Leukemia) [2][54.55%]
1. [NCIT:C3172](markdown/NCIT_C3172.md) (Myeloid Leukemia) [100][62.04%]
1. [NCIT:C3174](markdown/NCIT_C3174.md) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive) [9][55.92%]
1. [NCIT:C3178](markdown/NCIT_C3178.md) (Chronic Myelomonocytic Leukemia) [4][55.02%]
1. [NCIT:C3181](markdown/NCIT_C3181.md) (Prolymphocytic Leukemia) [7][54.67%]
1. [NCIT:C3182](markdown/NCIT_C3182.md) (Acute Promyelocytic Leukemia with PML-RARA) [4][61.54%]
1. [NCIT:C3183](markdown/NCIT_C3183.md) (T Acute Lymphoblastic Leukemia) [4][58.33%]
1. [NCIT:C3192](markdown/NCIT_C3192.md) (Lipoma) [41][54.67%]
1. [NCIT:C3193](markdown/NCIT_C3193.md) (Lipomatosis) [6][53.35%]
1. [NCIT:C3209](markdown/NCIT_C3209.md) (Follicular Lymphoma) [42][54.67%]
1. [NCIT:C3212](markdown/NCIT_C3212.md) (Lymphoplasmacytic Lymphoma) [10][53.64%]
1. [NCIT:C3222](markdown/NCIT_C3222.md) (Medulloblastoma) [21][54.81%]
1. [NCIT:C3230](markdown/NCIT_C3230.md) (Meningioma) [37][56.03%]
1. [NCIT:C3234](markdown/NCIT_C3234.md) (Mesothelioma) [48][56.41%]
1. [NCIT:C3242](markdown/NCIT_C3242.md) (Plasma Cell Myeloma) [4][54.15%]
1. [NCIT:C3246](markdown/NCIT_C3246.md) (Mycosis Fungoides) [6][55.00%]
1. [NCIT:C3247](markdown/NCIT_C3247.md) (Myelodysplastic Syndrome) [23][57.09%]
1. [NCIT:C3249](markdown/NCIT_C3249.md) (Acute Myeloid Leukemia without Maturation) [2][54.17%]
1. [NCIT:C3250](markdown/NCIT_C3250.md) (Acute Myeloid Leukemia with Maturation) [2][54.55%]
1. [NCIT:C3264](markdown/NCIT_C3264.md) (Embryonal Neoplasm) [180][62.18%]
1. [NCIT:C3267](markdown/NCIT_C3267.md) (Wilms Tumor) [19][56.90%]
1. [NCIT:C3269](markdown/NCIT_C3269.md) (Schwannoma) [6][53.64%]
1. [NCIT:C3270](markdown/NCIT_C3270.md) (Neuroblastoma) [24][55.08%]
1. [NCIT:C3272](markdown/NCIT_C3272.md) (Neurofibroma) [11][53.33%]
1. [NCIT:C3288](markdown/NCIT_C3288.md) (Oligodendroglioma) [9][53.90%]
1. [NCIT:C3296](markdown/NCIT_C3296.md) (Osteoma) [3][60.00%]
1. [NCIT:C3326](markdown/NCIT_C3326.md) (Adrenal Gland Pheochromocytoma) [10][53.55%]
1. [NCIT:C3329](markdown/NCIT_C3329.md) (Pituitary Gland Adenoma) [23][55.52%]
1. [NCIT:C3336](markdown/NCIT_C3336.md) (Polycythemia Vera) [2][54.95%]
1. [NCIT:C3340](markdown/NCIT_C3340.md) (Polyp) [54][56.03%]
1. [NCIT:C3358](markdown/NCIT_C3358.md) (Rhabdomyoma) [9][55.00%]
1. [NCIT:C3359](markdown/NCIT_C3359.md) (Rhabdomyosarcoma) [34][58.93%]
1. [NCIT:C3363](markdown/NCIT_C3363.md) (Sebaceous Gland Neoplasm) [10][53.57%]
1. [NCIT:C3371](markdown/NCIT_C3371.md) (Skin Disorder) [387][64.21%]
1. [NCIT:C3377](markdown/NCIT_C3377.md) (Soft Tissue Neoplasm) [564][66.21%]
1. [NCIT:C3379](markdown/NCIT_C3379.md) (Somatostatin-Producing Neuroendocrine Tumor) [7][53.57%]
1. [NCIT:C3402](markdown/NCIT_C3402.md) (Tenosynovial Giant Cell Tumor) [2][53.04%]
1. [NCIT:C3403](markdown/NCIT_C3403.md) (Teratoma) [43][53.55%]
1. [NCIT:C3411](markdown/NCIT_C3411.md) (Thymoma) [26][55.46%]
1. [NCIT:C3422](markdown/NCIT_C3422.md) (Trophoblastic Tumor) [25][64.00%]
1. [NCIT:C3434](markdown/NCIT_C3434.md) (Uterine Corpus Leiomyoma) [8][59.09%]
1. [NCIT:C3460](markdown/NCIT_C3460.md) (Grade 3 Follicular Lymphoma) [8][53.57%]
1. [NCIT:C3461](markdown/NCIT_C3461.md) (Immunoblastic Lymphoma) [9][55.56%]
1. [NCIT:C3465](markdown/NCIT_C3465.md) (Grade 1 Follicular Lymphoma) [6][53.57%]
1. [NCIT:C3466](markdown/NCIT_C3466.md) (T-Cell Non-Hodgkin Lymphoma) [113][59.80%]
1. [NCIT:C3473](markdown/NCIT_C3473.md) (Choroid Plexus Neoplasm) [7][54.17%]
1. [NCIT:C3491](markdown/NCIT_C3491.md) (Cecum Carcinoma) [2][58.33%]
1. [NCIT:C3493](markdown/NCIT_C3493.md) (Squamous Cell Lung Carcinoma) [13][54.23%]
1. [NCIT:C3502](markdown/NCIT_C3502.md) (Thyroid Gland Follicular Adenoma) [2][54.35%]
1. [NCIT:C3512](markdown/NCIT_C3512.md) (Lung Adenocarcinoma) [19][55.02%]
1. [NCIT:C3513](markdown/NCIT_C3513.md) (Esophageal Carcinoma) [47][55.08%]
1. [NCIT:C3518](markdown/NCIT_C3518.md) (Nodular Sclerosis Classical Hodgkin Lymphoma) [4][60.00%]
1. [NCIT:C3520](markdown/NCIT_C3520.md) (Myeloid Sarcoma) [6][54.55%]
1. [NCIT:C3576](markdown/NCIT_C3576.md) (Malignant Thoracic Neoplasm) [223][61.13%]
1. [NCIT:C3580](markdown/NCIT_C3580.md) (Metastatic Malignant Neoplasm in the Bone) [5][58.33%]
1. [NCIT:C3605](markdown/NCIT_C3605.md) (Benign Cardiac Neoplasm) [20][53.33%]
1. [NCIT:C3608](markdown/NCIT_C3608.md) (Benign Uterine Corpus Neoplasm) [18][54.15%]
1. [NCIT:C3616](markdown/NCIT_C3616.md) (Benign Renal Pelvis Neoplasm) [2][58.33%]
1. [NCIT:C3624](markdown/NCIT_C3624.md) (Benign Retinal Neoplasm) [4][66.67%]
1. [NCIT:C3627](markdown/NCIT_C3627.md) (Benign Spinal Cord Neoplasm) [3][66.67%]
1. [NCIT:C3628](markdown/NCIT_C3628.md) (Benign Thyroid Gland Neoplasm) [3][54.07%]
1. [NCIT:C3629](markdown/NCIT_C3629.md) (Benign Adrenal Gland Neoplasm) [9][63.33%]
1. [NCIT:C3630](markdown/NCIT_C3630.md) (Benign Parathyroid Gland Neoplasm) [7][53.99%]
1. [NCIT:C3640](markdown/NCIT_C3640.md) (Stage 0 Skin Cancer) [3][54.17%]
1. [NCIT:C3641](markdown/NCIT_C3641.md) (Stage 0 Breast Cancer AJCC v6 and v7) [7][56.94%]
1. [NCIT:C3680](markdown/NCIT_C3680.md) (Cribriform Carcinoma) [9][55.56%]
1. [NCIT:C3686](markdown/NCIT_C3686.md) (Salivary Gland Monomorphic Adenoma) [5][55.56%]
1. [NCIT:C3687](markdown/NCIT_C3687.md) (Renal Papillary Adenoma) [2][56.25%]
1. [NCIT:C3692](markdown/NCIT_C3692.md) (Undifferentiated Carcinoma) [37][55.64%]
1. [NCIT:C3696](markdown/NCIT_C3696.md) (Subependymal Giant Cell Astrocytoma) [3][52.70%]
1. [NCIT:C3697](markdown/NCIT_C3697.md) (Myxopapillary Ependymoma) [2][58.33%]
1. [NCIT:C3708](markdown/NCIT_C3708.md) (Germ Cell Tumor) [164][57.63%]
1. [NCIT:C3709](markdown/NCIT_C3709.md) (Epithelial Neoplasm) [2675][77.16%]
1. [NCIT:C3713](markdown/NCIT_C3713.md) (Papillomatosis) [7][55.56%]
1. [NCIT:C3714](markdown/NCIT_C3714.md) (Epithelioid Sarcoma) [7][55.00%]
1. [NCIT:C3716](markdown/NCIT_C3716.md) (Primitive Neuroectodermal Tumor) [58][56.20%]
1. [NCIT:C3720](markdown/NCIT_C3720.md) (Anaplastic Large Cell Lymphoma) [28][55.34%]
1. [NCIT:C3721](markdown/NCIT_C3721.md) (Lymphomatoid Papulosis) [5][53.57%]
1. [NCIT:C3723](markdown/NCIT_C3723.md) (Lymphatic Vessel Neoplasm) [18][55.56%]
1. [NCIT:C3726](markdown/NCIT_C3726.md) (Adenomyoma) [2][66.67%]
1. [NCIT:C3727](markdown/NCIT_C3727.md) (Adenosquamous Carcinoma) [31][55.08%]
1. [NCIT:C3729](markdown/NCIT_C3729.md) (Malignant Mixed Neoplasm) [80][57.72%]
1. [NCIT:C3730](markdown/NCIT_C3730.md) (Mixed Mesodermal (Mullerian) Tumor) [51][54.46%]
1. [NCIT:C3732](markdown/NCIT_C3732.md) (Pulmonary Blastoma) [2][60.00%]
1. [NCIT:C3737](markdown/NCIT_C3737.md) (Mesenchymal Chondrosarcoma) [4][57.14%]
1. [NCIT:C3738](markdown/NCIT_C3738.md) (Osteoclastic Giant Cell-Rich Tumor of Bone) [6][54.55%]
1. [NCIT:C3743](markdown/NCIT_C3743.md) (Fibroepithelial Neoplasm) [22][54.53%]
1. [NCIT:C3744](markdown/NCIT_C3744.md) (Breast Fibroadenoma) [5][56.25%]
1. [NCIT:C3746](markdown/NCIT_C3746.md) (Small Cell Sarcoma) [9][53.55%]
1. [NCIT:C3747](markdown/NCIT_C3747.md) (Angioleiomyoma) [3][56.25%]
1. [NCIT:C3748](markdown/NCIT_C3748.md) (Leiomyomatosis) [4][57.14%]
1. [NCIT:C3749](markdown/NCIT_C3749.md) (Alveolar Rhabdomyosarcoma) [3][75.00%]
1. [NCIT:C3750](markdown/NCIT_C3750.md) (Alveolar Soft Part Sarcoma) [7][53.35%]
1. [NCIT:C3751](markdown/NCIT_C3751.md) (Smooth Muscle Neoplasm) [108][56.95%]
1. [NCIT:C3752](markdown/NCIT_C3752.md) (Embryonal Carcinoma) [10][57.14%]
1. [NCIT:C3753](markdown/NCIT_C3753.md) (Germinoma) [2][75.00%]
1. [NCIT:C3758](markdown/NCIT_C3758.md) (Hepatocellular Adenoma) [3][52.93%]
1. [NCIT:C3759](markdown/NCIT_C3759.md) (Oncocytic Adenoma) [2][66.67%]
1. [NCIT:C3760](markdown/NCIT_C3760.md) (Hidrocystoma) [2][66.67%]
1. [NCIT:C3762](markdown/NCIT_C3762.md) (Adenomatoid Tumor) [8][64.73%]
1. [NCIT:C3764](markdown/NCIT_C3764.md) (Adenomatous Polyp) [10][53.73%]
1. [NCIT:C3769](markdown/NCIT_C3769.md) (Endometrioid Adenocarcinoma) [19][53.90%]
1. [NCIT:C3770](markdown/NCIT_C3770.md) (Pancreatic Neuroendocrine Carcinoma) [4][57.14%]
1. [NCIT:C3771](markdown/NCIT_C3771.md) (Lobular Breast Carcinoma) [9][53.35%]
1. [NCIT:C3772](markdown/NCIT_C3772.md) (Mucoepidermoid Carcinoma) [27][53.99%]
1. [NCIT:C3774](markdown/NCIT_C3774.md) (Signet Ring Cell Carcinoma) [18][60.00%]
1. [NCIT:C3780](markdown/NCIT_C3780.md) (Large Cell Carcinoma) [59][55.87%]
1. [NCIT:C3781](markdown/NCIT_C3781.md) (Verrucous Carcinoma) [15][54.55%]
1. [NCIT:C3782](markdown/NCIT_C3782.md) (Cervical Intraepithelial Neoplasia) [13][51.99%]
1. [NCIT:C3786](markdown/NCIT_C3786.md) (Mesothelial Neoplasm) [49][56.56%]
1. [NCIT:C3787](markdown/NCIT_C3787.md) (Neuroepithelial Neoplasm) [307][63.15%]
1. [NCIT:C3788](markdown/NCIT_C3788.md) (Ganglioglioma) [2][53.25%]
1. [NCIT:C3789](markdown/NCIT_C3789.md) (Olfactory Neuroblastoma) [3][55.56%]
1. [NCIT:C3790](markdown/NCIT_C3790.md) (Ganglioneuroblastoma) [10][54.55%]
1. [NCIT:C3792](markdown/NCIT_C3792.md) (Squamous Cell Neoplasm) [279][60.76%]
1. [NCIT:C3794](markdown/NCIT_C3794.md) (Sex Cord-Stromal Tumor) [10][53.25%]
1. [NCIT:C3796](markdown/NCIT_C3796.md) (Gliosarcoma) [6][57.14%]
1. [NCIT:C3798](markdown/NCIT_C3798.md) (Malignant Peripheral Nerve Sheath Tumor) [18][54.07%]
1. [NCIT:C3799](markdown/NCIT_C3799.md) (Angiofibroma) [5][54.17%]
1. [NCIT:C3800](markdown/NCIT_C3800.md) (Epithelioid Hemangioendothelioma) [8][53.45%]
1. [NCIT:C3801](markdown/NCIT_C3801.md) (Hemangioblastoma) [4][54.55%]
1. [NCIT:C3803](markdown/NCIT_C3803.md) (Blue Nevus) [2][57.14%]
1. [NCIT:C3808](markdown/NCIT_C3808.md) (Rhabdoid Tumor) [6][53.57%]
1. [NCIT:C3809](markdown/NCIT_C3809.md) (Neuroendocrine Neoplasm) [309][62.45%]
1. [NCIT:C3842](markdown/NCIT_C3842.md) (Urothelial Papilloma) [9][62.50%]
1. [NCIT:C3844](markdown/NCIT_C3844.md) (Gallbladder Carcinoma) [39][54.15%]
1. [NCIT:C3860](markdown/NCIT_C3860.md) (Extrahepatic Bile Duct Carcinoma) [30][53.82%]
1. [NCIT:C3861](markdown/NCIT_C3861.md) (Ependymal Tumor of Brain) [9][53.85%]
1. [NCIT:C3864](markdown/NCIT_C3864.md) (Colon Adenoma) [8][62.50%]
1. [NCIT:C3867](markdown/NCIT_C3867.md) (Fallopian Tube Carcinoma) [16][53.45%]
1. [NCIT:C3868](markdown/NCIT_C3868.md) (Gastrointestinal Stromal Tumor) [28][53.90%]
1. [NCIT:C3871](markdown/NCIT_C3871.md) (Nasopharyngeal Carcinoma) [34][53.73%]
1. [NCIT:C3873](markdown/NCIT_C3873.md) (Ovarian Germ Cell Tumor) [40][54.55%]
1. [NCIT:C3879](markdown/NCIT_C3879.md) (Thyroid Gland Medullary Carcinoma) [7][53.55%]
1. [NCIT:C3898](markdown/NCIT_C3898.md) (Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue) [22][54.23%]
1. [NCIT:C3915](markdown/NCIT_C3915.md) (Small Cell Carcinoma) [32][55.98%]
1. [NCIT:C3916](markdown/NCIT_C3916.md) (Parathyroid Gland Adenoma) [6][53.82%]
1. [NCIT:C3917](markdown/NCIT_C3917.md) (Vaginal Carcinoma) [18][53.85%]
1. [NCIT:C3938](markdown/NCIT_C3938.md) (Turcot Syndrome) [2][53.25%]
1. [NCIT:C4001](markdown/NCIT_C4001.md) (Inflammatory Breast Carcinoma) [2][58.33%]
1. [NCIT:C4004](markdown/NCIT_C4004.md) (Gastric Adenocarcinoma) [16][54.15%]
1. [NCIT:C4016](markdown/NCIT_C4016.md) (Malignant Bone Neoplasm) [85][58.30%]
1. [NCIT:C4017](markdown/NCIT_C4017.md) (Ductal Breast Carcinoma) [21][57.28%]
1. [NCIT:C4024](markdown/NCIT_C4024.md) (Esophageal Squamous Cell Carcinoma) [14][55.00%]
1. [NCIT:C4025](markdown/NCIT_C4025.md) (Esophageal Adenocarcinoma) [9][53.35%]
1. [NCIT:C4028](markdown/NCIT_C4028.md) (Cervical Squamous Cell Carcinoma, Not Otherwise Specified) [10][55.56%]
1. [NCIT:C4030](markdown/NCIT_C4030.md) (Urothelial Carcinoma) [52][56.09%]
1. [NCIT:C4031](markdown/NCIT_C4031.md) (Bladder Squamous Cell Carcinoma) [10][53.57%]
1. [NCIT:C4032](markdown/NCIT_C4032.md) (Bladder Adenocarcinoma) [6][58.33%]
1. [NCIT:C4033](markdown/NCIT_C4033.md) (Clear Cell Renal Cell Carcinoma) [6][53.57%]
1. [NCIT:C4035](markdown/NCIT_C4035.md) (Thyroid Gland Papillary Carcinoma) [10][54.67%]
1. [NCIT:C4036](markdown/NCIT_C4036.md) (Myelodysplastic Syndrome with Ring Sideroblasts) [2][56.67%]
1. [NCIT:C4043](markdown/NCIT_C4043.md) (Hypopharyngeal Squamous Cell Carcinoma) [6][66.67%]
1. [NCIT:C4044](markdown/NCIT_C4044.md) (Laryngeal Squamous Cell Carcinoma) [9][53.45%]
1. [NCIT:C4045](markdown/NCIT_C4045.md) (Childhood Oligodendroglioma) [2][75.00%]
1. [NCIT:C4047](markdown/NCIT_C4047.md) (Pilocytic Astrocytoma) [5][53.73%]
1. [NCIT:C4049](markdown/NCIT_C4049.md) (Anaplastic Ependymoma) [2][55.63%]
1. [NCIT:C4050](markdown/NCIT_C4050.md) (Oligoastrocytoma) [3][53.85%]
1. [NCIT:C4052](markdown/NCIT_C4052.md) (Vulvar Squamous Cell Carcinoma) [6][62.50%]
1. [NCIT:C4063](markdown/NCIT_C4063.md) (Myomatous Neoplasm) [159][58.53%]
1. [NCIT:C4074](markdown/NCIT_C4074.md) (Centroblastic Lymphoma) [7][55.00%]
1. [NCIT:C4083](markdown/NCIT_C4083.md) (Hyperplastic Polyp) [3][57.14%]
1. [NCIT:C4092](markdown/NCIT_C4092.md) (Benign Epithelial Neoplasm) [181][61.39%]
1. [NCIT:C4102](markdown/NCIT_C4102.md) (Papillary Squamous Cell Carcinoma) [26][53.45%]
1. [NCIT:C4105](markdown/NCIT_C4105.md) (Keratinizing Squamous Cell Carcinoma) [23][54.15%]
1. [NCIT:C4107](markdown/NCIT_C4107.md) (Nasopharyngeal Type Undifferentiated Carcinoma) [19][53.85%]
1. [NCIT:C4113](markdown/NCIT_C4113.md) (Tricholemmoma) [2][60.00%]
1. [NCIT:C4115](markdown/NCIT_C4115.md) (Transitional Cell Papilloma) [11][58.33%]
1. [NCIT:C4120](markdown/NCIT_C4120.md) (Sarcomatoid Transitional Cell Carcinoma) [4][55.56%]
1. [NCIT:C4121](markdown/NCIT_C4121.md) (Basaloid Carcinoma) [12][54.31%]
1. [NCIT:C4122](markdown/NCIT_C4122.md) (Papillary Transitional Cell Carcinoma) [8][53.33%]
1. [NCIT:C4126](markdown/NCIT_C4126.md) (Intestinal-Type Adenocarcinoma) [6][58.33%]
1. [NCIT:C4127](markdown/NCIT_C4127.md) (Diffuse Type Adenocarcinoma) [3][56.25%]
1. [NCIT:C4129](markdown/NCIT_C4129.md) (Bile Duct Mucinous Cystic Neoplasm) [7][52.57%]
1. [NCIT:C4133](markdown/NCIT_C4133.md) (Tubular Adenoma) [9][56.25%]
1. [NCIT:C4137](markdown/NCIT_C4137.md) (Solid Carcinoma) [7][53.85%]
1. [NCIT:C4139](markdown/NCIT_C4139.md) (Combined Carcinoid and Adenocarcinoma) [2][55.56%]
1. [NCIT:C4143](markdown/NCIT_C4143.md) (Tubulovillous Adenoma) [8][56.25%]
1. [NCIT:C4146](markdown/NCIT_C4146.md) (Chromophobe Renal Cell Carcinoma) [2][54.17%]
1. [NCIT:C4159](markdown/NCIT_C4159.md) (Lipoadenoma) [2][60.00%]
1. [NCIT:C4171](markdown/NCIT_C4171.md) (Papillary Hidradenoma) [2][66.67%]
1. [NCIT:C4194](markdown/NCIT_C4194.md) (Invasive Ductal Carcinoma, Not Otherwise Specified) [2][54.31%]
1. [NCIT:C4197](markdown/NCIT_C4197.md) (Acinar Cell Neoplasm) [10][55.02%]
1. [NCIT:C4199](markdown/NCIT_C4199.md) (Epithelial-Myoepithelial Carcinoma) [2][60.00%]
1. [NCIT:C4216](markdown/NCIT_C4216.md) (Sympathetic Paraganglioma) [15][54.23%]
1. [NCIT:C4217](markdown/NCIT_C4217.md) (Parasympathetic Paraganglioma) [7][53.25%]
1. [NCIT:C4220](markdown/NCIT_C4220.md) (Malignant Adrenal Gland Pheochromocytoma) [2][75.00%]
1. [NCIT:C4222](markdown/NCIT_C4222.md) (Glomangioma) [2][62.50%]
1. [NCIT:C4237](markdown/NCIT_C4237.md) (Spindle Cell Melanoma) [2][57.14%]
1. [NCIT:C4246](markdown/NCIT_C4246.md) (Atypical Fibroxanthoma) [2][56.25%]
1. [NCIT:C4247](markdown/NCIT_C4247.md) (Undifferentiated Pleomorphic Sarcoma) [8][53.73%]
1. [NCIT:C4248](markdown/NCIT_C4248.md) (Lipomatous Neoplasm) [81][57.93%]
1. [NCIT:C4250](markdown/NCIT_C4250.md) (Well Differentiated Liposarcoma) [2][53.55%]
1. [NCIT:C4263](markdown/NCIT_C4263.md) (Low Grade Endometrioid Stromal Sarcoma) [4][54.17%]
1. [NCIT:C4274](markdown/NCIT_C4274.md) (Benign Phyllodes Tumor) [2][75.00%]
1. [NCIT:C4275](markdown/NCIT_C4275.md) (Malignant Phyllodes Tumor) [3][64.73%]
1. [NCIT:C4286](markdown/NCIT_C4286.md) (Immature Teratoma) [6][75.00%]
1. [NCIT:C4298](markdown/NCIT_C4298.md) (Epithelioid Hemangioma) [3][51.63%]
1. [NCIT:C4318](markdown/NCIT_C4318.md) (Gliomatosis Cerebri) [4][53.57%]
1. [NCIT:C4320](markdown/NCIT_C4320.md) (Protoplasmic Astrocytoma) [2][60.00%]
1. [NCIT:C4321](markdown/NCIT_C4321.md) (Gemistocytic Astrocytoma) [3][66.67%]
1. [NCIT:C4322](markdown/NCIT_C4322.md) (Fibrillary Astrocytoma) [2][62.50%]
1. [NCIT:C4323](markdown/NCIT_C4323.md) (Pleomorphic Xanthoastrocytoma) [2][54.55%]
1. [NCIT:C4325](markdown/NCIT_C4325.md) (Giant Cell Glioblastoma) [3][66.67%]
1. [NCIT:C4326](markdown/NCIT_C4326.md) (Anaplastic Oligodendroglioma) [5][53.35%]
1. [NCIT:C4337](markdown/NCIT_C4337.md) (Mantle Cell Lymphoma) [14][53.82%]
1. [NCIT:C4340](markdown/NCIT_C4340.md) (Peripheral T-Cell Lymphoma, Not Otherwise Specified) [4][54.07%]
1. [NCIT:C4341](markdown/NCIT_C4341.md) (Marginal Zone Lymphoma) [39][55.64%]
1. [NCIT:C4342](markdown/NCIT_C4342.md) (Intravascular Large B-Cell Lymphoma) [4][55.00%]
1. [NCIT:C4345](markdown/NCIT_C4345.md) (Myeloproliferative Neoplasm) [20][59.06%]
1. [NCIT:C4381](markdown/NCIT_C4381.md) (Ovarian Epithelial Tumor) [87][56.90%]
1. [NCIT:C4397](markdown/NCIT_C4397.md) (Carcinoma ex Pleomorphic Adenoma) [6][56.25%]
1. [NCIT:C4436](markdown/NCIT_C4436.md) (Cholangiocarcinoma) [32][57.50%]
1. [NCIT:C4437](markdown/NCIT_C4437.md) (Liver Sarcoma) [5][66.67%]
1. [NCIT:C4447](markdown/NCIT_C4447.md) (Benign Retroperitoneal Neoplasm) [10][61.11%]
1. [NCIT:C4450](markdown/NCIT_C4450.md) (Large Cell Lung Carcinoma) [13][53.82%]
1. [NCIT:C4456](markdown/NCIT_C4456.md) (Malignant Mesothelioma) [30][55.27%]
1. [NCIT:C4463](markdown/NCIT_C4463.md) (Skin Appendage Neoplasm) [108][58.14%]
1. [NCIT:C4505](markdown/NCIT_C4505.md) (Benign Breast Neoplasm) [18][53.33%]
1. [NCIT:C4508](markdown/NCIT_C4508.md) (Ovarian Seromucinous Tumor) [5][52.82%]
1. [NCIT:C4517](markdown/NCIT_C4517.md) (Benign Fallopian Tube Neoplasm) [6][60.00%]
1. [NCIT:C4521](markdown/NCIT_C4521.md) (Vaginal Intraepithelial Neoplasia) [3][75.00%]
1. [NCIT:C4533](markdown/NCIT_C4533.md) (Malignant Choroid Plexus Neoplasm) [2][58.33%]
1. [NCIT:C4536](markdown/NCIT_C4536.md) (Pituitary Gland Carcinoma) [4][81.25%]
1. [NCIT:C4565](markdown/NCIT_C4565.md) (Benign Thoracic Neoplasm) [51][54.88%]
1. [NCIT:C4571](markdown/NCIT_C4571.md) (Malignant Respiratory Tract Neoplasm) [129][58.80%]
1. [NCIT:C4596](markdown/NCIT_C4596.md) (Penile Intraepithelial Neoplasia) [4][62.50%]
1. [NCIT:C4600](markdown/NCIT_C4600.md) (Benign Salivary Gland Neoplasm) [27][55.15%]
1. [NCIT:C4607](markdown/NCIT_C4607.md) (Benign Myocardial Neoplasm) [2][62.50%]
1. [NCIT:C4610](markdown/NCIT_C4610.md) (Benign Colorectal Neoplasm) [15][60.00%]
1. [NCIT:C4642](markdown/NCIT_C4642.md) (Brain Glioblastoma) [9][55.00%]
1. [NCIT:C4663](markdown/NCIT_C4663.md) (Splenic Marginal Zone Lymphoma) [2][53.85%]
1. [NCIT:C4664](markdown/NCIT_C4664.md) (T-Cell Large Granular Lymphocyte Leukemia) [3][54.17%]
1. [NCIT:C4665](markdown/NCIT_C4665.md) (Plasma Cell Neoplasm) [14][55.08%]
1. [NCIT:C4671](markdown/NCIT_C4671.md) (Breast Lymphoma) [8][75.00%]
1. [NCIT:C4683](markdown/NCIT_C4683.md) (Dermatofibrosarcoma Protuberans) [2][54.17%]
1. [NCIT:C4684](markdown/NCIT_C4684.md) (Nasal Type Extranodal NK/T-Cell Lymphoma) [9][53.64%]
1. [NCIT:C4711](markdown/NCIT_C4711.md) (Borderline Cystadenoma) [4][66.67%]
1. [NCIT:C4727](markdown/NCIT_C4727.md) (Post-Transplant Lymphoproliferative Disorder) [18][54.81%]
1. [NCIT:C4737](markdown/NCIT_C4737.md) (Enteropathy-Associated T-Cell Lymphoma) [6][57.14%]
1. [NCIT:C4742](markdown/NCIT_C4742.md) (Benign Squamous Cell Neoplasm) [18][53.55%]
1. [NCIT:C4747](markdown/NCIT_C4747.md) (Neuronal and Mixed Neuronal-Glial Tumors) [17][56.51%]
1. [NCIT:C4748](markdown/NCIT_C4748.md) (Malignant Melanotic Peripheral Nerve Sheath Tumor) [2][66.67%]
1. [NCIT:C4752](markdown/NCIT_C4752.md) (T-Cell Prolymphocytic Leukemia) [3][53.73%]
1. [NCIT:C4755](markdown/NCIT_C4755.md) (Chondrogenic Neoplasm) [32][56.86%]
1. [NCIT:C4776](markdown/NCIT_C4776.md) (Benign Extrahepatic Bile Duct Neoplasm) [6][58.33%]
1. [NCIT:C4777](markdown/NCIT_C4777.md) (Benign Male Reproductive System Neoplasm) [12][54.17%]
1. [NCIT:C4778](markdown/NCIT_C4778.md) (Benign Kidney Neoplasm) [12][54.07%]
1. [NCIT:C4780](markdown/NCIT_C4780.md) (Benign Eye Neoplasm) [19][53.57%]
1. [NCIT:C4783](markdown/NCIT_C4783.md) (Borderline Ovarian Epithelial Tumor) [18][55.56%]
1. [NCIT:C4787](markdown/NCIT_C4787.md) (Benign Digestive System Neoplasm) [60][54.88%]
1. [NCIT:C4788](markdown/NCIT_C4788.md) (Malignant Nervous System Neoplasm) [264][61.07%]
1. [NCIT:C4793](markdown/NCIT_C4793.md) (Colon Lymphoma) [8][58.33%]
1. [NCIT:C4803](markdown/NCIT_C4803.md) (Duodenal Carcinoma) [3][60.00%]
1. [NCIT:C4815](markdown/NCIT_C4815.md) (Thyroid Gland Carcinoma) [43][57.41%]
1. [NCIT:C4819](markdown/NCIT_C4819.md) (Skin Squamous Cell Carcinoma) [15][53.33%]
1. [NCIT:C4822](markdown/NCIT_C4822.md) (Malignant Glioma) [66][57.19%]
1. [NCIT:C4824](markdown/NCIT_C4824.md) (Tongue Carcinoma) [5][66.67%]
1. [NCIT:C4839](markdown/NCIT_C4839.md) (Esophageal Intraepithelial Neoplasia) [13][57.14%]
1. [NCIT:C4845](markdown/NCIT_C4845.md) (Pancreatic Intraepithelial Neoplasia) [5][53.25%]
1. [NCIT:C4855](markdown/NCIT_C4855.md) (Laryngeal Carcinoma) [34][54.23%]
1. [NCIT:C4861](markdown/NCIT_C4861.md) (Acute Monocytic Leukemia) [3][62.50%]
1. [NCIT:C4862](markdown/NCIT_C4862.md) (Ovarian Sex Cord-Stromal Tumor) [7][54.17%]
1. [NCIT:C4863](markdown/NCIT_C4863.md) (Prostate Carcinoma) [28][55.46%]
1. [NCIT:C4867](markdown/NCIT_C4867.md) (Malignant Soft Tissue Neoplasm) [301][61.65%]
1. [NCIT:C4872](markdown/NCIT_C4872.md) (Breast Carcinoma) [115][60.00%]
1. [NCIT:C4878](markdown/NCIT_C4878.md) (Lung Carcinoma) [105][58.14%]
1. [NCIT:C4880](markdown/NCIT_C4880.md) (Benign Bone Neoplasm) [18][55.15%]
1. [NCIT:C4884](markdown/NCIT_C4884.md) (Benign Neck Neoplasm) [28][56.90%]
1. [NCIT:C4890](markdown/NCIT_C4890.md) (Malignant Digestive System Neoplasm) [730][64.56%]
1. [NCIT:C4893](markdown/NCIT_C4893.md) (Benign Urinary System Neoplasm) [30][54.88%]
1. [NCIT:C4906](markdown/NCIT_C4906.md) (Parathyroid Gland Carcinoma) [4][58.33%]
1. [NCIT:C4908](markdown/NCIT_C4908.md) (Ovarian Carcinoma) [21][55.27%]
1. [NCIT:C4911](markdown/NCIT_C4911.md) (Gastric Carcinoma) [43][55.15%]
1. [NCIT:C4912](markdown/NCIT_C4912.md) (Bladder Carcinoma) [57][56.25%]
1. [NCIT:C4915](markdown/NCIT_C4915.md) (Embryonal Tumor with Multilayered Rosettes, C19MC-Altered) [5][55.00%]
1. [NCIT:C4917](markdown/NCIT_C4917.md) (Small Cell Lung Carcinoma) [2][54.23%]
1. [NCIT:C4951](markdown/NCIT_C4951.md) (Cerebral Astrocytoma) [5][62.50%]
1. [NCIT:C4952](markdown/NCIT_C4952.md) (Primary Brain Neoplasm) [46][53.33%]
1. [NCIT:C4972](markdown/NCIT_C4972.md) (Nerve Sheath Neoplasm) [66][57.19%]
1. [NCIT:C4973](markdown/NCIT_C4973.md) (Perineurioma) [2][55.00%]
1. [NCIT:C4983](markdown/NCIT_C4983.md) (Aleukemic Leukemia Cutis) [2][66.67%]
1. [NCIT:C5006](markdown/NCIT_C5006.md) (Stage IV Follicular Lymphoma) [3][54.55%]
1. [NCIT:C5007](markdown/NCIT_C5007.md) (Recurrent Follicular Lymphoma) [3][55.00%]
1. [NCIT:C5027](markdown/NCIT_C5027.md) (Malignant Testicular Non-Seminomatous Germ Cell Tumor) [3][75.00%]
1. [NCIT:C5028](markdown/NCIT_C5028.md) (Verrucous Lesion) [10][53.35%]
1. [NCIT:C5105](markdown/NCIT_C5105.md) (Colorectal Adenocarcinoma) [33][54.35%]
1. [NCIT:C5111](markdown/NCIT_C5111.md) (Benign Intracranial Neoplasm) [30][54.53%]
1. [NCIT:C5117](markdown/NCIT_C5117.md) (Spiradenocarcinoma) [2][60.00%]
1. [NCIT:C5136](markdown/NCIT_C5136.md) (Childhood Glioblastoma) [6][62.50%]
1. [NCIT:C5160](markdown/NCIT_C5160.md) (Mixed Lobular and Ductal Breast Carcinoma) [6][57.14%]
1. [NCIT:C5197](markdown/NCIT_C5197.md) (Benign Nipple Neoplasm) [2][52.57%]
1. [NCIT:C5206](markdown/NCIT_C5206.md) (Papillary Breast Neoplasm) [13][52.57%]
1. [NCIT:C5226](markdown/NCIT_C5226.md) (Borderline Ovarian Serous Tumor) [2][62.50%]
1. [NCIT:C5237](markdown/NCIT_C5237.md) (Ovarian Neuroendocrine Neoplasm) [5][53.85%]
1. [NCIT:C5242](markdown/NCIT_C5242.md) (Ovarian Mucinous Tumor) [9][55.56%]
1. [NCIT:C5244](markdown/NCIT_C5244.md) (Ovarian Soft Tissue Neoplasm) [13][56.25%]
1. [NCIT:C5265](markdown/NCIT_C5265.md) (Thyroid Gland Lymphoma) [3][75.00%]
1. [NCIT:C5308](markdown/NCIT_C5308.md) (Ectopic Meningioma) [4][58.33%]
1. [NCIT:C5322](markdown/NCIT_C5322.md) (Central Nervous System Anaplastic Large Cell Lymphoma) [2][75.00%]
1. [NCIT:C5327](markdown/NCIT_C5327.md) (Head and Neck Paraganglioma) [7][55.56%]
1. [NCIT:C5340](markdown/NCIT_C5340.md) (Small Intestinal Adenoma) [5][55.56%]
1. [NCIT:C5348](markdown/NCIT_C5348.md) (Great Vessel Neoplasm) [9][80.80%]
1. [NCIT:C5387](markdown/NCIT_C5387.md) (Leiomyosarcoma of Vessels) [5][65.36%]
1. [NCIT:C5398](markdown/NCIT_C5398.md) (Central Nervous System Embryonal Tumor, Not Otherwise Specified) [10][57.14%]
1. [NCIT:C5495](markdown/NCIT_C5495.md) (Colon Sarcoma) [2][75.00%]
1. [NCIT:C5545](markdown/NCIT_C5545.md) (Prostate Neuroendocrine Neoplasm) [2][58.33%]
1. [NCIT:C5546](markdown/NCIT_C5546.md) (Rectal Adenoma) [7][66.67%]
1. [NCIT:C5591](markdown/NCIT_C5591.md) (Benign Childhood Central Nervous System Neoplasm) [5][53.82%]
1. [NCIT:C5596](markdown/NCIT_C5596.md) (Prostate Acinar Adenocarcinoma) [2][53.64%]
1. [NCIT:C5598](markdown/NCIT_C5598.md) (Paget Disease of the Anus) [2][62.50%]
1. [NCIT:C5669](markdown/NCIT_C5669.md) (Pleuropulmonary Blastoma) [3][53.35%]
1. [NCIT:C5673](markdown/NCIT_C5673.md) (Colorectal Adenoma) [28][54.07%]
1. [NCIT:C5676](markdown/NCIT_C5676.md) (Colorectal Villous Adenoma) [3][58.33%]
1. [NCIT:C5685](markdown/NCIT_C5685.md) (Colorectal Adenoma with Severe Dysplasia) [2][75.00%]
1. [NCIT:C5697](markdown/NCIT_C5697.md) (Colon Neuroendocrine Neoplasm) [10][58.33%]
1. [NCIT:C5698](markdown/NCIT_C5698.md) (Rectal Neuroendocrine Neoplasm) [6][66.67%]
1. [NCIT:C5716](markdown/NCIT_C5716.md) (Borderline Exocrine Pancreatic Neoplasm) [13][54.67%]
1. [NCIT:C5749](markdown/NCIT_C5749.md) (Liver and Intrahepatic Bile Duct Benign Non-Epithelial Neoplasm) [6][60.00%]
1. [NCIT:C5803](markdown/NCIT_C5803.md) (Small Intestinal Neuroendocrine Neoplasm) [18][60.00%]
1. [NCIT:C5821](markdown/NCIT_C5821.md) (Esophageal Neuroendocrine Neoplasm) [6][53.85%]
1. [NCIT:C5857](markdown/NCIT_C5857.md) (Extrahepatic Bile Duct Adenoma) [3][66.67%]
1. [NCIT:C5908](markdown/NCIT_C5908.md) (Salivary Gland Mucoepidermoid Carcinoma) [6][66.67%]
1. [NCIT:C6014](markdown/NCIT_C6014.md) (Paranasal Sinus Carcinoma) [12][55.56%]
1. [NCIT:C6120](markdown/NCIT_C6120.md) (Conjunctival Intraepithelial Neoplasia) [2][75.00%]
1. [NCIT:C6287](markdown/NCIT_C6287.md) (Endometrial Endometrioid Adenocarcinoma) [11][53.57%]
1. [NCIT:C6410](markdown/NCIT_C6410.md) (Cardiac Paraganglioma) [2][62.50%]
1. [NCIT:C6421](markdown/NCIT_C6421.md) (Foregut Carcinoid Tumor) [8][53.73%]
1. [NCIT:C6423](markdown/NCIT_C6423.md) (Hindgut Carcinoid Tumor) [3][58.33%]
1. [NCIT:C6431](markdown/NCIT_C6431.md) (Metastatic Carcinoid Tumor) [2][62.50%]
1. [NCIT:C6432](markdown/NCIT_C6432.md) (Multiple Endocrine Neoplasia) [4][53.33%]
1. [NCIT:C6437](markdown/NCIT_C6437.md) (Mediastinal Germ Cell Tumor) [3][58.33%]
1. [NCIT:C6449](markdown/NCIT_C6449.md) (Benign Germ Cell Tumor) [5][62.50%]
1. [NCIT:C6451](markdown/NCIT_C6451.md) (Thymic Lymphoma) [7][53.33%]
1. [NCIT:C6481](markdown/NCIT_C6481.md) (Inflammatory Myofibroblastic Tumor) [9][53.99%]
1. [NCIT:C6498](markdown/NCIT_C6498.md) (Deep Lipoma) [4][57.14%]
1. [NCIT:C6514](markdown/NCIT_C6514.md) (Skeletal Muscle Neoplasm) [44][63.89%]
1. [NCIT:C6528](markdown/NCIT_C6528.md) (Pericytic Neoplasm) [20][55.02%]
1. [NCIT:C6555](markdown/NCIT_C6555.md) (Deep Hemangioma) [3][57.14%]
1. [NCIT:C6569](markdown/NCIT_C6569.md) (Congenital Mesoblastic Nephroma) [3][53.57%]
1. [NCIT:C6570](markdown/NCIT_C6570.md) (Extraskeletal Cartilaginous and Osseous Neoplasm) [17][53.33%]
1. [NCIT:C6577](markdown/NCIT_C6577.md) (Myxoma) [11][56.67%]
1. [NCIT:C6591](markdown/NCIT_C6591.md) (Peripheral Neuroblastoma) [2][54.17%]
1. [NCIT:C6603](markdown/NCIT_C6603.md) (Osteogenic Neoplasm) [48][55.81%]
1. [NCIT:C6624](markdown/NCIT_C6624.md) (Mediastinal Neural Neoplasm) [5][57.14%]
1. [NCIT:C6650](markdown/NCIT_C6650.md) (Ampulla of Vater Adenocarcinoma) [5][54.17%]
1. [NCIT:C6657](markdown/NCIT_C6657.md) (Ampulla of Vater Intestinal-Type Adenoma) [3][54.17%]
1. [NCIT:C6770](markdown/NCIT_C6770.md) (Ependymal Tumor) [39][55.81%]
1. [NCIT:C6781](markdown/NCIT_C6781.md) (Stromal Neoplasm) [53][56.41%]
1. [NCIT:C6796](markdown/NCIT_C6796.md) (Eccrine Neoplasm) [13][56.52%]
1. [NCIT:C6798](markdown/NCIT_C6798.md) (Apocrine Neoplasm) [10][62.50%]
1. [NCIT:C6813](markdown/NCIT_C6813.md) (Prostate Ductal Adenocarcinoma) [3][51.63%]
1. [NCIT:C6814](markdown/NCIT_C6814.md) (Superficial Fibromatosis) [2][58.33%]
1. [NCIT:C6860](markdown/NCIT_C6860.md) (Primary Cutaneous Anaplastic Large Cell Lymphoma) [2][53.57%]
1. [NCIT:C6875](markdown/NCIT_C6875.md) (Large Cell Neuroendocrine Carcinoma) [20][53.82%]
1. [NCIT:C6881](markdown/NCIT_C6881.md) (Bile Duct Papillary Neoplasm) [7][63.64%]
1. [NCIT:C6894](markdown/NCIT_C6894.md) (Malignant Solitary Fibrous Tumor) [3][56.25%]
1. [NCIT:C6899](markdown/NCIT_C6899.md) (Breast Adenomyoepithelioma) [2][58.33%]
1. [NCIT:C6906](markdown/NCIT_C6906.md) (Atypical Teratoid/Rhabdoid Tumor) [2][66.67%]
1. [NCIT:C6913](markdown/NCIT_C6913.md) (Lymphocyte-Rich Classical Hodgkin Lymphoma) [3][66.67%]
1. [NCIT:C6919](markdown/NCIT_C6919.md) (T Lymphoblastic Lymphoma) [4][57.14%]
1. [NCIT:C6930](markdown/NCIT_C6930.md) (Mixed Neoplasm) [185][60.73%]
1. [NCIT:C6958](markdown/NCIT_C6958.md) (Astrocytic Tumor) [116][58.22%]
1. [NCIT:C6959](markdown/NCIT_C6959.md) (Anaplastic Oligoastrocytoma) [3][53.57%]
1. [NCIT:C6960](markdown/NCIT_C6960.md) (Oligodendroglial Tumor) [17][54.81%]
1. [NCIT:C6963](markdown/NCIT_C6963.md) (Neuroblastic Tumor) [43][55.87%]
1. [NCIT:C6965](markdown/NCIT_C6965.md) (Pineal Parenchymal Cell Neoplasm) [10][53.73%]
1. [NCIT:C6971](markdown/NCIT_C6971.md) (Meningothelial Cell Neoplasm) [43][56.41%]
1. [NCIT:C6974](markdown/NCIT_C6974.md) (Neoplasm of Uncertain Histogenesis) [5][53.57%]
1. [NCIT:C6975](markdown/NCIT_C6975.md) (Papillary Renal Cell Carcinoma) [4][53.55%]
1. [NCIT:C6990](markdown/NCIT_C6990.md) (Central Nervous System Embryonal Neoplasm) [56][56.71%]
1. [NCIT:C7046](markdown/NCIT_C7046.md) (Urinary System Paraganglioma) [2][57.14%]
1. [NCIT:C7055](markdown/NCIT_C7055.md) (Precursor Lymphoid Neoplasm) [87][57.68%]
1. [NCIT:C7058](markdown/NCIT_C7058.md) (Melanocytic Neoplasm) [111][57.85%]
1. [NCIT:C7059](markdown/NCIT_C7059.md) (Mesenchymal Cell Neoplasm) [509][67.15%]
1. [NCIT:C7061](markdown/NCIT_C7061.md) (Retinal Cell Neoplasm) [16][54.88%]
1. [NCIT:C7063](markdown/NCIT_C7063.md) (Notochordal Tumor) [6][53.82%]
1. [NCIT:C7064](markdown/NCIT_C7064.md) (Erythroid Neoplasm) [6][55.34%]
1. [NCIT:C7066](markdown/NCIT_C7066.md) (Megakaryocytic Neoplasm) [4][54.88%]
1. [NCIT:C7068](markdown/NCIT_C7068.md) (Neoplastic Polyp) [18][54.60%]
1. [NCIT:C7069](markdown/NCIT_C7069.md) (Giant Cell Neoplasm) [23][55.87%]
1. [NCIT:C7070](markdown/NCIT_C7070.md) (Mucinous Neoplasm) [60][55.81%]
1. [NCIT:C7074](markdown/NCIT_C7074.md) (Serous Neoplasm) [57][55.98%]
1. [NCIT:C7075](markdown/NCIT_C7075.md) (Fibroblastic Neoplasm) [90][59.35%]
1. [NCIT:C7103](markdown/NCIT_C7103.md) (Liver and Intrahepatic Bile Duct Neoplasm) [132][59.52%]
1. [NCIT:C7106](markdown/NCIT_C7106.md) (Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [98][57.89%]
1. [NCIT:C7107](markdown/NCIT_C7107.md) (Liver and Intrahepatic Bile Duct Non-Epithelial Neoplasm) [24][54.84%]
1. [NCIT:C7109](markdown/NCIT_C7109.md) (Distal Bile Duct Carcinoma) [10][55.56%]
1. [NCIT:C7113](markdown/NCIT_C7113.md) (Endometrioid Tumor) [39][54.88%]
1. [NCIT:C7114](markdown/NCIT_C7114.md) (Thymoma Type B) [5][55.88%]
1. [NCIT:C7128](markdown/NCIT_C7128.md) (Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm) [5][51.41%]
1. [NCIT:C7130](markdown/NCIT_C7130.md) (Gallbladder Papillary Neoplasm) [3][58.33%]
1. [NCIT:C7132](markdown/NCIT_C7132.md) (Glandular Cell Neoplasm) [724][69.20%]
1. [NCIT:C7134](markdown/NCIT_C7134.md) (Bone Surface (Peripheral) Osteosarcoma) [5][62.50%]
1. [NCIT:C7161](markdown/NCIT_C7161.md) (Melanocytic Skin Neoplasm) [66][56.30%]
1. [NCIT:C7164](markdown/NCIT_C7164.md) (Classical Hodgkin Lymphoma) [31][58.08%]
1. [NCIT:C7171](markdown/NCIT_C7171.md) (Acute Monoblastic Leukemia) [2][75.00%]
1. [NCIT:C7173](markdown/NCIT_C7173.md) (Diffuse Astrocytoma) [17][53.73%]
1. [NCIT:C7175](markdown/NCIT_C7175.md) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities) [29][57.63%]
1. [NCIT:C7195](markdown/NCIT_C7195.md) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder) [6][54.07%]
1. [NCIT:C7224](markdown/NCIT_C7224.md) (Plasmablastic Lymphoma) [3][62.50%]
1. [NCIT:C7232](markdown/NCIT_C7232.md) (Neoplastic Post-Transplant Lymphoproliferative Disorder) [16][54.67%]
1. [NCIT:C7233](markdown/NCIT_C7233.md) (Monomorphic Post-Transplant Lymphoproliferative Disorder) [11][53.55%]
1. [NCIT:C7237](markdown/NCIT_C7237.md) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder) [9][52.57%]
1. [NCIT:C7240](markdown/NCIT_C7240.md) (Plasma Cell Post-Transplant Lymphoproliferative Disorder) [2][51.99%]
1. [NCIT:C7258](markdown/NCIT_C7258.md) (Nodular Lymphocyte Predominant Hodgkin Lymphoma) [8][58.33%]
1. [NCIT:C7264](markdown/NCIT_C7264.md) (Diffuse Follicular Lymphoma) [2][62.50%]
1. [NCIT:C7287](markdown/NCIT_C7287.md) (Ovarian Granulosa-Stromal Cell Tumor) [3][57.14%]
1. [NCIT:C7290](markdown/NCIT_C7290.md) (Ovarian Tumor of the Thecoma/Fibroma Group) [2][62.50%]
1. [NCIT:C7296](markdown/NCIT_C7296.md) (Splenic Manifestation of Leukemia) [7][54.60%]
1. [NCIT:C7297](markdown/NCIT_C7297.md) (Splenic Manifestation of Prolymphocytic Leukemia) [2][58.33%]
1. [NCIT:C7312](markdown/NCIT_C7312.md) (Splenic Lymphoblastic Lymphoma) [2][75.00%]
1. [NCIT:C7313](markdown/NCIT_C7313.md) (Benign Ovarian Serous Tumor) [5][75.00%]
1. [NCIT:C7318](markdown/NCIT_C7318.md) (Acute Monoblastic and Monocytic Leukemia) [9][63.64%]
1. [NCIT:C7335](markdown/NCIT_C7335.md) (Reproductive Endocrine Neoplasm) [15][53.99%]
1. [NCIT:C7355](markdown/NCIT_C7355.md) (Renal Pelvis Urothelial Carcinoma) [5][66.67%]
1. [NCIT:C7372](markdown/NCIT_C7372.md) (Cerebellar Neuronal and Mixed Neuronal-Glial Tumor) [2][53.33%]
1. [NCIT:C7373](markdown/NCIT_C7373.md) (Nasopharyngeal Nonkeratinizing Carcinoma) [7][54.17%]
1. [NCIT:C7376](markdown/NCIT_C7376.md) (Pleural Malignant Mesothelioma) [16][53.82%]
1. [NCIT:C7387](markdown/NCIT_C7387.md) (Blood Vessel Neoplasm) [143][58.14%]
1. [NCIT:C7388](markdown/NCIT_C7388.md) (Vascular Neoplasm) [171][58.57%]
1. [NCIT:C7399](markdown/NCIT_C7399.md) (Villous Adenoma) [11][53.85%]
1. [NCIT:C7400](markdown/NCIT_C7400.md) (Burkitt Leukemia) [2][57.14%]
1. [NCIT:C7402](markdown/NCIT_C7402.md) (Hairy Cell Leukemia) [3][56.25%]
1. [NCIT:C7421](markdown/NCIT_C7421.md) (Rectosigmoid Carcinoma) [14][64.29%]
1. [NCIT:C7457](markdown/NCIT_C7457.md) (Capillary Hemangioma) [10][56.25%]
1. [NCIT:C7463](markdown/NCIT_C7463.md) (Acute Myelomonocytic Leukemia) [4][54.31%]
1. [NCIT:C7464](markdown/NCIT_C7464.md) (Acute Leukemia of Ambiguous Lineage) [11][54.38%]
1. [NCIT:C7489](markdown/NCIT_C7489.md) (Anal Canal Carcinoma) [17][54.17%]
1. [NCIT:C7506](markdown/NCIT_C7506.md) (Myelodysplastic Syndrome with Excess Blasts) [3][54.31%]
1. [NCIT:C7515](markdown/NCIT_C7515.md) (Renal Pelvis and Ureter Carcinoma) [33][54.17%]
1. [NCIT:C7528](markdown/NCIT_C7528.md) (Angioimmunoblastic T-Cell Lymphoma) [7][53.73%]
1. [NCIT:C7540](markdown/NCIT_C7540.md) (Small Lymphocytic Lymphoma) [10][53.25%]
1. [NCIT:C7541](markdown/NCIT_C7541.md) (Retinoblastoma) [13][54.38%]
1. [NCIT:C7558](markdown/NCIT_C7558.md) (Endometrial Carcinoma) [31][54.67%]
1. [NCIT:C7563](markdown/NCIT_C7563.md) (Hidradenoma) [3][83.33%]
1. [NCIT:C7569](markdown/NCIT_C7569.md) (Thymic Carcinoma) [13][54.07%]
1. [NCIT:C7570](markdown/NCIT_C7570.md) (Melanocytic Nevus) [30][54.95%]
1. [NCIT:C7574](markdown/NCIT_C7574.md) (Prostate Phyllodes Tumor) [2][75.00%]
1. [NCIT:C7596](markdown/NCIT_C7596.md) (Malignant Myoepithelioma) [3][51.82%]
1. [NCIT:C7600](markdown/NCIT_C7600.md) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes) [3][54.67%]
1. [NCIT:C7608](markdown/NCIT_C7608.md) (Benign Oral Neoplasm) [18][53.55%]
1. [NCIT:C7611](markdown/NCIT_C7611.md) (Cerebral Lymphoma) [3][62.50%]
1. [NCIT:C7612](markdown/NCIT_C7612.md) (Malignant Thymoma) [8][55.00%]
1. [NCIT:C7617](markdown/NCIT_C7617.md) (Benign Reproductive System Neoplasm) [123][57.55%]
1. [NCIT:C7632](markdown/NCIT_C7632.md) (Pericardial Mesothelioma) [3][66.67%]
1. [NCIT:C7634](markdown/NCIT_C7634.md) (Solitary Fibrous Tumor) [14][54.17%]
1. [NCIT:C7635](markdown/NCIT_C7635.md) (Well Differentiated Papillary Mesothelioma) [2][54.55%]
1. [NCIT:C7656](markdown/NCIT_C7656.md) (Liver Dysplastic Nodule) [2][56.25%]
1. [NCIT:C7676](markdown/NCIT_C7676.md) (Adenocarcinoma in Adenomatous Polyp) [9][62.05%]
1. [NCIT:C7708](markdown/NCIT_C7708.md) (Childhood Malignant Liver Neoplasm) [11][53.73%]
1. [NCIT:C7709](markdown/NCIT_C7709.md) (Digestive System Neuroendocrine Tumor G1) [20][53.45%]
1. [NCIT:C7715](markdown/NCIT_C7715.md) (Childhood Soft Tissue Sarcoma) [14][53.33%]
1. [NCIT:C7718](markdown/NCIT_C7718.md) (Appendix Adenocarcinoma) [6][58.33%]
1. [NCIT:C7720](markdown/NCIT_C7720.md) (Gallbladder Adenoma) [3][60.00%]
1. [NCIT:C7721](markdown/NCIT_C7721.md) (Gingival Carcinoma) [9][80.00%]
1. [NCIT:C7724](markdown/NCIT_C7724.md) (Small Intestinal Carcinoma) [31][54.60%]
1. [NCIT:C7731](markdown/NCIT_C7731.md) (Prostate Sarcoma) [6][58.33%]
1. [NCIT:C7764](markdown/NCIT_C7764.md) (Atypical Lymphoproliferative Disorder) [5][53.33%]
1. [NCIT:C7888](markdown/NCIT_C7888.md) (Small Intestinal Adenocarcinoma) [11][53.45%]
1. [NCIT:C7909](markdown/NCIT_C7909.md) (ACTH-Producing Pituitary Gland Neoplasm) [2][62.50%]
1. [NCIT:C7910](markdown/NCIT_C7910.md) (Prolactin-Producing Pituitary Gland Neoplasm) [2][53.35%]
1. [NCIT:C7911](markdown/NCIT_C7911.md) (Growth Hormone-Producing Pituitary Gland Neoplasm) [2][55.88%]
1. [NCIT:C7915](markdown/NCIT_C7915.md) (TSH-Producing Pituitary Gland Neoplasm) [2][57.14%]
1. [NCIT:C7927](markdown/NCIT_C7927.md) (Liver and Intrahepatic Bile Duct Carcinoma) [79][57.05%]
1. [NCIT:C7930](markdown/NCIT_C7930.md) (Lymphomatoid Granulomatosis) [14][53.45%]
1. [NCIT:C7933](markdown/NCIT_C7933.md) (Grade III Lymphomatoid Granulomatosis) [5][57.14%]
1. [NCIT:C7934](markdown/NCIT_C7934.md) (Recurrent Lymphomatoid Granulomatosis) [6][75.00%]
1. [NCIT:C7975](markdown/NCIT_C7975.md) (Extrahepatic Bile Duct Adenocarcinoma) [7][53.85%]
1. [NCIT:C7981](markdown/NCIT_C7981.md) (Vaginal Adenocarcinoma) [4][58.33%]
1. [NCIT:C7991](markdown/NCIT_C7991.md) (Salivary Gland Squamous Cell Carcinoma) [4][66.67%]
1. [NCIT:C7992](markdown/NCIT_C7992.md) (Nasopharyngeal Keratinizing Squamous Cell Carcinoma) [7][57.79%]
1. [NCIT:C8026](markdown/NCIT_C8026.md) (Salivary Gland Adenoid Cystic Carcinoma) [4][75.00%]
1. [NCIT:C8054](markdown/NCIT_C8054.md) (Thyroid Gland Follicular Carcinoma) [6][53.33%]
1. [NCIT:C8106](markdown/NCIT_C8106.md) (Ovarian Dysgerminoma) [4][75.00%]
1. [NCIT:C8107](markdown/NCIT_C8107.md) (Ovarian Yolk Sac Tumor) [6][51.63%]
1. [NCIT:C8108](markdown/NCIT_C8108.md) (Ovarian Embryonal Carcinoma) [4][75.00%]
1. [NCIT:C8193](markdown/NCIT_C8193.md) (Paranasal Sinus Squamous Cell Carcinoma) [2][66.67%]
1. [NCIT:C8264](markdown/NCIT_C8264.md) (Childhood Meningioma) [3][58.63%]
1. [NCIT:C8294](markdown/NCIT_C8294.md) (Pancreatic Adenocarcinoma) [18][56.76%]
1. [NCIT:C8300](markdown/NCIT_C8300.md) (Desmoplastic Small Round Cell Tumor) [3][54.17%]
1. [NCIT:C8334](markdown/NCIT_C8334.md) (Squamous Cell Intraepithelial Neoplasia) [33][53.45%]
1. [NCIT:C8366](markdown/NCIT_C8366.md) (Intraepithelial Neoplasia) [118][58.22%]
1. [NCIT:C8383](markdown/NCIT_C8383.md) (Kidney Adenoma) [4][53.55%]
1. [NCIT:C8402](markdown/NCIT_C8402.md) (Fibrohistiocytic Neoplasm) [18][55.08%]
1. [NCIT:C8417](markdown/NCIT_C8417.md) (Benign Ear Neoplasm) [7][52.44%]
1. [NCIT:C8460](markdown/NCIT_C8460.md) (Acute Myeloid Leukemia with Minimal Differentiation) [2][53.33%]
1. [NCIT:C8493](markdown/NCIT_C8493.md) (Hereditary Breast and Ovarian Cancer Syndrome) [2][54.05%]
1. [NCIT:C8494](markdown/NCIT_C8494.md) (Lynch Syndrome) [2][59.53%]
1. [NCIT:C8513](markdown/NCIT_C8513.md) (Stage I Colorectal Cancer AJCC v6 and v7) [3][62.50%]
1. [NCIT:C8514](markdown/NCIT_C8514.md) (Stage II Colorectal Cancer AJCC v6) [3][62.50%]
1. [NCIT:C8515](markdown/NCIT_C8515.md) (Stage III Colorectal Cancer AJCC v6) [3][62.50%]
1. [NCIT:C8531](markdown/NCIT_C8531.md) (Benign Respiratory Tract Neoplasm) [18][53.35%]
1. [NCIT:C8536](markdown/NCIT_C8536.md) (Benign Pericardial Neoplasm) [2][75.00%]
1. [NCIT:C8559](markdown/NCIT_C8559.md) (Malignant Paraganglioma) [9][60.00%]
1. [NCIT:C8563](markdown/NCIT_C8563.md) (Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [6][53.85%]
1. [NCIT:C8588](markdown/NCIT_C8588.md) (Childhood Ovarian Germ Cell Tumor) [2][75.00%]
1. [NCIT:C8591](markdown/NCIT_C8591.md) (Testicular Germ Cell Tumor) [14][53.55%]
1. [NCIT:C8602](markdown/NCIT_C8602.md) (Pleomorphic Adenoma) [7][53.45%]
1. [NCIT:C8603](markdown/NCIT_C8603.md) (Renal Pelvis Papillary Urothelial Neoplasm) [4][58.33%]
1. [NCIT:C8612](markdown/NCIT_C8612.md) (Benign Peritoneal Neoplasm) [2][62.50%]
1. [NCIT:C8644](markdown/NCIT_C8644.md) (B Acute Lymphoblastic Leukemia) [12][55.08%]
1. [NCIT:C8694](markdown/NCIT_C8694.md) (T Lymphoblastic Leukemia/Lymphoma) [18][54.38%]
1. [NCIT:C8810](markdown/NCIT_C8810.md) (Extraskeletal Osteosarcoma) [10][60.00%]
1. [NCIT:C8851](markdown/NCIT_C8851.md) (Diffuse Large B-Cell Lymphoma) [88][58.06%]
1. [NCIT:C8859](markdown/NCIT_C8859.md) (Stage I Follicular Lymphoma) [3][54.55%]
1. [NCIT:C8860](markdown/NCIT_C8860.md) (Stage II Follicular Lymphoma) [3][54.55%]
1. [NCIT:C8861](markdown/NCIT_C8861.md) (Stage III Follicular Lymphoma) [3][54.55%]
1. [NCIT:C8863](markdown/NCIT_C8863.md) (Nodal Marginal Zone Lymphoma) [7][55.00%]
1. [NCIT:C8868](markdown/NCIT_C8868.md) (B Lymphoblastic Lymphoma) [9][58.33%]
1. [NCIT:C8923](markdown/NCIT_C8923.md) (Acute Erythroid Leukemia) [2][60.00%]
1. [NCIT:C8936](markdown/NCIT_C8936.md) (B Lymphoblastic Leukemia/Lymphoma) [33][56.14%]
1. [NCIT:C8964](markdown/NCIT_C8964.md) (Synovial Neoplasm) [5][53.35%]
1. [NCIT:C8968](markdown/NCIT_C8968.md) (Grade 2 Follicular Lymphoma) [6][53.57%]
1. [NCIT:C8971](markdown/NCIT_C8971.md) (Embryonal Rhabdomyosarcoma) [3][55.56%]
1. [NCIT:C8973](markdown/NCIT_C8973.md) (Endometrioid Stromal Sarcoma) [7][55.56%]
1. [NCIT:C8975](markdown/NCIT_C8975.md) (Malignant Mixed Mesodermal (Mullerian) Tumor) [7][56.25%]
1. [NCIT:C8978](markdown/NCIT_C8978.md) (Mucinous Adenofibroma) [3][75.00%]
1. [NCIT:C8984](markdown/NCIT_C8984.md) (Female Reproductive System Adenofibroma) [29][54.55%]
1. [NCIT:C8990](markdown/NCIT_C8990.md) (Oral Cavity Carcinoma) [53][64.29%]
1. [NCIT:C9003](markdown/NCIT_C9003.md) (Adrenal Cortex Adenoma) [3][54.55%]
1. [NCIT:C9015](markdown/NCIT_C9015.md) (Mature Teratoma) [8][75.00%]
1. [NCIT:C9039](markdown/NCIT_C9039.md) (Cervical Carcinoma) [40][54.46%]
1. [NCIT:C9055](markdown/NCIT_C9055.md) (Bartholin Gland Carcinoma) [6][66.67%]
1. [NCIT:C9063](markdown/NCIT_C9063.md) (Malignant Testicular Germ Cell Tumor) [9][55.56%]
1. [NCIT:C9087](markdown/NCIT_C9087.md) (Kaposi Sarcoma) [30][53.55%]
1. [NCIT:C9093](markdown/NCIT_C9093.md) (Adult Meningioma) [6][58.63%]
1. [NCIT:C9094](markdown/NCIT_C9094.md) (Adult Glioblastoma) [5][56.25%]
1. [NCIT:C9105](markdown/NCIT_C9105.md) (Oropharyngeal Carcinoma) [27][60.00%]
1. [NCIT:C9118](markdown/NCIT_C9118.md) (Sarcoma) [451][65.35%]
1. [NCIT:C9120](markdown/NCIT_C9120.md) (Pancreatic Ductal Adenocarcinoma) [9][55.58%]
1. [NCIT:C9133](markdown/NCIT_C9133.md) (Adenosquamous Lung Carcinoma) [7][55.00%]
1. [NCIT:C9152](markdown/NCIT_C9152.md) (Superficial Spreading Melanoma) [4][60.00%]
1. [NCIT:C9154](markdown/NCIT_C9154.md) (Adult Acute Myeloid Leukemia) [17][62.50%]
1. [NCIT:C9159](markdown/NCIT_C9159.md) (Diffuse Gastric Adenocarcinoma) [2][58.33%]
1. [NCIT:C9161](markdown/NCIT_C9161.md) (Anal Squamous Cell Carcinoma) [5][62.50%]
1. [NCIT:C9166](markdown/NCIT_C9166.md) (Gallbladder Adenocarcinoma) [8][54.17%]
1. [NCIT:C9182](markdown/NCIT_C9182.md) (Desmoid-Type Fibromatosis) [4][55.00%]
1. [NCIT:C9231](markdown/NCIT_C9231.md) (Merkel Cell Carcinoma) [9][54.55%]
1. [NCIT:C9235](markdown/NCIT_C9235.md) (Systemic Mastocytosis) [7][54.31%]
1. [NCIT:C9240](markdown/NCIT_C9240.md) (Recurrent Nasopharynx Carcinoma) [2][57.79%]
1. [NCIT:C9245](markdown/NCIT_C9245.md) (Invasive Breast Carcinoma) [46][57.14%]
1. [NCIT:C9265](markdown/NCIT_C9265.md) (Mycosis Fungoides and Sezary Syndrome) [15][54.17%]
1. [NCIT:C9280](markdown/NCIT_C9280.md) (Mediastinal (Thymic) Large B-Cell Lymphoma) [6][54.17%]
1. [NCIT:C9283](markdown/NCIT_C9283.md) (Lymphocyte-Depleted Classical Hodgkin Lymphoma) [8][75.00%]
1. [NCIT:C9287](markdown/NCIT_C9287.md) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11) [4][53.55%]
1. [NCIT:C9290](markdown/NCIT_C9290.md) (Myeloid Neoplasm) [178][66.05%]
1. [NCIT:C9292](markdown/NCIT_C9292.md) (Solid Neoplasm) [6][66.67%]
1. [NCIT:C9294](markdown/NCIT_C9294.md) (Histiocytic and Dendritic Cell Neoplasm) [26][56.86%]
1. [NCIT:C9295](markdown/NCIT_C9295.md) (Mast Cell Neoplasm) [14][55.02%]
1. [NCIT:C9301](markdown/NCIT_C9301.md) (Central Nervous System Lymphoma) [18][55.00%]
1. [NCIT:C9303](markdown/NCIT_C9303.md) (Mastocytoma) [2][66.67%]
1. [NCIT:C9306](markdown/NCIT_C9306.md) (Soft Tissue Sarcoma) [279][61.16%]
1. [NCIT:C9308](markdown/NCIT_C9308.md) (Lymphoproliferative Disorder) [774][69.78%]
1. [NCIT:C9309](markdown/NCIT_C9309.md) (Seminoma) [4][57.14%]
1. [NCIT:C9312](markdown/NCIT_C9312.md) (Bone Sarcoma) [51][57.09%]
1. [NCIT:C9325](markdown/NCIT_C9325.md) (Adrenal Cortex Carcinoma) [7][53.35%]
1. [NCIT:C9336](markdown/NCIT_C9336.md) (Nasal Cavity Carcinoma) [10][55.00%]
1. [NCIT:C9344](markdown/NCIT_C9344.md) (Pineoblastoma) [3][54.55%]
1. [NCIT:C9347](markdown/NCIT_C9347.md) (Tracheal Carcinoma) [3][58.33%]
1. [NCIT:C9349](markdown/NCIT_C9349.md) (Plasmacytoma) [4][54.55%]
1. [NCIT:C9351](markdown/NCIT_C9351.md) (Pleural Mesothelioma) [19][53.99%]
1. [NCIT:C9357](markdown/NCIT_C9357.md) (Hodgkin Lymphoma) [75][55.92%]
1. [NCIT:C9360](markdown/NCIT_C9360.md) (Lymphoblastic Lymphoma) [28][53.33%]
1. [NCIT:C9377](markdown/NCIT_C9377.md) (Brain Oligodendroglioma) [2][66.67%]
1. [NCIT:C9384](markdown/NCIT_C9384.md) (Kidney Carcinoma) [46][57.55%]
1. [NCIT:C9385](markdown/NCIT_C9385.md) (Renal Cell Carcinoma) [28][56.81%]
1. [NCIT:C9429](markdown/NCIT_C9429.md) (Conventional Fibrosarcoma) [2][53.33%]
1. [NCIT:C9446](markdown/NCIT_C9446.md) (Grade 1 Colorectal Adenocarcinoma) [2][58.33%]
1. [NCIT:C9447](markdown/NCIT_C9447.md) (Grade 2 Colorectal Adenocarcinoma) [2][58.33%]
1. [NCIT:C9448](markdown/NCIT_C9448.md) (Grade 3 Colorectal Adenocarcinoma) [2][58.33%]
1. [NCIT:C9470](markdown/NCIT_C9470.md) (Systemic Anaplastic Large Cell Lymphoma) [4][60.00%]
1. [NCIT:C9474](markdown/NCIT_C9474.md) (Adenosarcoma) [5][57.14%]
1. [NCIT:C9475](markdown/NCIT_C9475.md) (Cerebellar Astrocytoma) [4][66.67%]
1. [NCIT:C9477](markdown/NCIT_C9477.md) (Anaplastic Astrocytoma) [14][53.82%]
1. [NCIT:C9482](markdown/NCIT_C9482.md) (Soft Tissue Chondroma) [3][51.99%]
1. [NCIT:C25765](markdown/NCIT_C25765.md) (Secondary Acute Myeloid Leukemia) [4][53.25%]
1. [NCIT:C26323](markdown/NCIT_C26323.md) (Hematologic and Lymphocytic Disorder) [1040][75.51%]
1. [NCIT:C26712](markdown/NCIT_C26712.md) (Mucinous Adenocarcinoma) [41][54.46%]
1. [NCIT:C27004](markdown/NCIT_C27004.md) (Sarcomatoid Carcinoma) [25][54.88%]
1. [NCIT:C27007](markdown/NCIT_C27007.md) (Spitz Nevus) [3][57.14%]
1. [NCIT:C27042](markdown/NCIT_C27042.md) (Soft Tissue Disorder) [566][66.29%]
1. [NCIT:C27067](markdown/NCIT_C27067.md) (Endocrine Pancreas Disorder) [34][55.46%]
1. [NCIT:C27084](markdown/NCIT_C27084.md) (Sarcomatoid Squamous Cell Carcinoma) [5][60.00%]
1. [NCIT:C27094](markdown/NCIT_C27094.md) (Cylindroma) [2][58.33%]
1. [NCIT:C27132](markdown/NCIT_C27132.md) (Trichoblastoma) [2][62.50%]
1. [NCIT:C27134](markdown/NCIT_C27134.md) (Hematopoietic and Lymphoid Cell Neoplasm) [1009][75.41%]
1. [NCIT:C27262](markdown/NCIT_C27262.md) (Myelodysplastic/Myeloproliferative Neoplasm) [10][57.05%]
1. [NCIT:C27269](markdown/NCIT_C27269.md) (Glandular Cell Intraepithelial Neoplasia) [46][55.98%]
1. [NCIT:C27273](markdown/NCIT_C27273.md) (Poroma) [4][57.14%]
1. [NCIT:C27291](markdown/NCIT_C27291.md) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [30][54.31%]
1. [NCIT:C27293](markdown/NCIT_C27293.md) (Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [5][66.67%]
1. [NCIT:C27294](markdown/NCIT_C27294.md) (Localized Primitive Neuroectodermal Tumor) [3][53.87%]
1. [NCIT:C27380](markdown/NCIT_C27380.md) (Thyroid Gland Adenocarcinoma) [24][55.70%]
1. [NCIT:C27423](markdown/NCIT_C27423.md) (Esophageal Squamous Intraepithelial Neoplasia) [3][64.29%]
1. [NCIT:C27462](markdown/NCIT_C27462.md) (Small Intestinal Intraepithelial Neoplasia) [2][66.67%]
1. [NCIT:C27467](markdown/NCIT_C27467.md) (Stage 0 Lung Cancer AJCC v6 and v7) [4][75.00%]
1. [NCIT:C27531](markdown/NCIT_C27531.md) (Pre-Malignant Skin Epithelial Lesion) [4][53.33%]
1. [NCIT:C27632](markdown/NCIT_C27632.md) (Transplant-Related Malignant Neoplasm) [23][54.60%]
1. [NCIT:C27639](markdown/NCIT_C27639.md) (Transplant-Related Hematologic Malignancy) [15][54.15%]
1. [NCIT:C27669](markdown/NCIT_C27669.md) (Respiratory and Thoracic Disorder) [387][62.92%]
1. [NCIT:C27675](markdown/NCIT_C27675.md) (Human Papillomavirus-Related Cervical Carcinoma) [5][57.14%]
1. [NCIT:C27676](markdown/NCIT_C27676.md) (Human Papillomavirus-Related Cervical Squamous Cell Carcinoma) [3][60.00%]
1. [NCIT:C27695](markdown/NCIT_C27695.md) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder) [2][57.14%]
1. [NCIT:C27696](markdown/NCIT_C27696.md) (EBV-Related Post-Transplant Lymphoproliferative Disorder) [3][55.00%]
1. [NCIT:C27716](markdown/NCIT_C27716.md) (Extragastrointestinal Gastrointestinal Stromal Tumor) [3][60.00%]
1. [NCIT:C27720](markdown/NCIT_C27720.md) (Pancreatic Neuroendocrine Tumor) [25][55.08%]
1. [NCIT:C27721](markdown/NCIT_C27721.md) (Digestive System Neuroendocrine Neoplasm) [181][58.46%]
1. [NCIT:C27814](markdown/NCIT_C27814.md) (Bile Duct Carcinoma) [68][55.08%]
1. [NCIT:C27880](markdown/NCIT_C27880.md) (Intraurothelial Neoplasia) [15][55.26%]
1. [NCIT:C27881](markdown/NCIT_C27881.md) (Transitional Cell Intraepithelial Neoplasia) [17][53.64%]
1. [NCIT:C27885](markdown/NCIT_C27885.md) (Infiltrating Bladder Urothelial Carcinoma) [14][55.02%]
1. [NCIT:C27891](markdown/NCIT_C27891.md) (Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions) [4][53.25%]
1. [NCIT:C27897](markdown/NCIT_C27897.md) (T-Cell Proliferation of Uncertain Malignant Potential) [7][53.82%]
1. [NCIT:C27907](markdown/NCIT_C27907.md) (B-Cell Neoplasm) [351][65.03%]
1. [NCIT:C27908](markdown/NCIT_C27908.md) (T-Cell and NK-Cell Neoplasm) [151][61.54%]
1. [NCIT:C27909](markdown/NCIT_C27909.md) (Mature T-Cell and NK-Cell Neoplasm) [120][60.83%]
1. [NCIT:C27910](markdown/NCIT_C27910.md) (Mature B-Cell Neoplasm) [308][64.00%]
1. [NCIT:C27911](markdown/NCIT_C27911.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) [28][54.67%]
1. [NCIT:C27912](markdown/NCIT_C27912.md) (Therapy-Related Myeloid Neoplasm) [8][54.74%]
1. [NCIT:C27913](markdown/NCIT_C27913.md) (Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome) [2][53.73%]
1. [NCIT:C27939](markdown/NCIT_C27939.md) (Lobular Neoplasia) [2][53.25%]
1. [NCIT:C27942](markdown/NCIT_C27942.md) (Intraductal Proliferative Lesion of the Breast) [4][56.94%]
1. [NCIT:C27949](markdown/NCIT_C27949.md) (Metaplastic Carcinoma) [19][53.99%]
1. [NCIT:C34448](markdown/NCIT_C34448.md) (Carcinosarcoma) [14][53.57%]
1. [NCIT:C34803](markdown/NCIT_C34803.md) (Primary Malignant Liver Neoplasm) [100][58.65%]
1. [NCIT:C35417](markdown/NCIT_C35417.md) (Intrahepatic Cholangiocarcinoma) [18][62.50%]
1. [NCIT:C35516](markdown/NCIT_C35516.md) (Gastrointestinal Polyp) [36][55.02%]
1. [NCIT:C35562](markdown/NCIT_C35562.md) (Neuroepithelial, Perineurial, and Schwann Cell Neoplasm) [375][64.62%]
1. [NCIT:C35870](markdown/NCIT_C35870.md) (Conventional Osteosarcoma) [4][53.90%]
1. [NCIT:C35871](markdown/NCIT_C35871.md) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone) [8][66.67%]
1. [NCIT:C36031](markdown/NCIT_C36031.md) (Papillary Neoplasm) [174][60.42%]
1. [NCIT:C36055](markdown/NCIT_C36055.md) (Acute Myeloid Leukemia with a Variant RARA Translocation) [4][53.35%]
1. [NCIT:C36077](markdown/NCIT_C36077.md) (Hilar Cholangiocarcinoma) [10][66.67%]
1. [NCIT:C36083](markdown/NCIT_C36083.md) (Intraductal Breast Neoplasm) [13][53.73%]
1. [NCIT:C36095](markdown/NCIT_C36095.md) (Cervical Mucinous Adenocarcinoma) [3][66.67%]
1. [NCIT:C36207](markdown/NCIT_C36207.md) (Digestive System Adenoma) [58][56.03%]
1. [NCIT:C36312](markdown/NCIT_C36312.md) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1) [2][53.35%]
1. [NCIT:C37193](markdown/NCIT_C37193.md) (Anaplastic Large Cell Lymphoma, ALK-Positive) [2][53.90%]
1. [NCIT:C37194](markdown/NCIT_C37194.md) (Anaplastic Large Cell Lymphoma, ALK-Negative) [2][57.14%]
1. [NCIT:C37201](markdown/NCIT_C37201.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation) [2][62.50%]
1. [NCIT:C37204](markdown/NCIT_C37204.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene) [2][57.14%]
1. [NCIT:C37263](markdown/NCIT_C37263.md) (Mixed Epithelial Stromal Tumor of the Kidney) [2][55.00%]
1. [NCIT:C37266](markdown/NCIT_C37266.md) (Bladder Flat Intraepithelial Lesion) [2][53.57%]
1. [NCIT:C37869](markdown/NCIT_C37869.md) (B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma) [3][62.50%]
1. [NCIT:C38342](markdown/NCIT_C38342.md) (Pancreatic Intraductal Papillary-Mucinous Neoplasm) [5][53.73%]
1. [NCIT:C38458](markdown/NCIT_C38458.md) (Traditional Serrated Adenoma) [4][53.25%]
1. [NCIT:C38936](markdown/NCIT_C38936.md) (Grade I Meningioma) [12][54.53%]
1. [NCIT:C38937](markdown/NCIT_C38937.md) (Grade II Meningioma) [6][53.99%]
1. [NCIT:C38938](markdown/NCIT_C38938.md) (Grade III Meningioma) [7][53.45%]
1. [NCIT:C39749](markdown/NCIT_C39749.md) (Type II Endometrial Adenocarcinoma) [4][52.57%]
1. [NCIT:C39750](markdown/NCIT_C39750.md) (Glioblastoma, IDH-Wildtype) [11][53.85%]
1. [NCIT:C39789](markdown/NCIT_C39789.md) (Hereditary Renal Cell Carcinoma) [2][58.33%]
1. [NCIT:C39842](markdown/NCIT_C39842.md) (Bladder Urachal Carcinoma) [2][75.00%]
1. [NCIT:C39851](markdown/NCIT_C39851.md) (Bladder Urothelial Carcinoma) [23][55.46%]
1. [NCIT:C39852](markdown/NCIT_C39852.md) (Urothelial Neoplasm) [71][56.56%]
1. [NCIT:C39857](markdown/NCIT_C39857.md) (Bladder Papillary Urothelial Neoplasm) [6][53.33%]
1. [NCIT:C39879](markdown/NCIT_C39879.md) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma) [3][57.14%]
1. [NCIT:C39904](markdown/NCIT_C39904.md) (Tumor of Specialized Prostatic Stroma) [2][58.33%]
1. [NCIT:C39950](markdown/NCIT_C39950.md) (Tumor of the Thecoma/Fibroma Group) [3][64.73%]
1. [NCIT:C39954](markdown/NCIT_C39954.md) (Brenner Tumor) [4][60.00%]
1. [NCIT:C39990](markdown/NCIT_C39990.md) (Ovarian Polyembryoma) [4][75.00%]
1. [NCIT:C40022](markdown/NCIT_C40022.md) (Primary Peritoneal Carcinoma) [7][53.33%]
1. [NCIT:C40023](markdown/NCIT_C40023.md) (Primary Peritoneal Serous Adenocarcinoma) [3][53.85%]
1. [NCIT:C40025](markdown/NCIT_C40025.md) (Malignant Ovarian Serous Tumor) [6][53.64%]
1. [NCIT:C40026](markdown/NCIT_C40026.md) (Malignant Ovarian Epithelial Tumor) [33][55.75%]
1. [NCIT:C40033](markdown/NCIT_C40033.md) (Malignant Ovarian Mucinous Tumor) [3][51.63%]
1. [NCIT:C40035](markdown/NCIT_C40035.md) (Adenocarcinofibroma) [3][66.67%]
1. [NCIT:C40051](markdown/NCIT_C40051.md) (Malignant Ovarian Endometrioid Tumor) [3][54.55%]
1. [NCIT:C40076](markdown/NCIT_C40076.md) (Ovarian Clear Cell Tumor) [11][52.82%]
1. [NCIT:C40077](markdown/NCIT_C40077.md) (Malignant Ovarian Clear Cell Tumor) [3][52.15%]
1. [NCIT:C40089](markdown/NCIT_C40089.md) (Malignant Ovarian Transitional Cell Tumor) [2][66.67%]
1. [NCIT:C40101](markdown/NCIT_C40101.md) (Serous Adenocarcinoma) [25][54.38%]
1. [NCIT:C40102](markdown/NCIT_C40102.md) (Fallopian Tube Serous Neoplasm) [7][53.33%]
1. [NCIT:C40106](markdown/NCIT_C40106.md) (Borderline Fallopian Tube Neoplasm) [3][56.25%]
1. [NCIT:C40109](markdown/NCIT_C40109.md) (Fallopian Tube Mucinous Neoplasm) [2][62.50%]
1. [NCIT:C40135](markdown/NCIT_C40135.md) (Uterine Ligament Adenocarcinoma) [7][64.29%]
1. [NCIT:C40179](markdown/NCIT_C40179.md) (Uterine Corpus Soft Tissue Neoplasm) [31][54.95%]
1. [NCIT:C40181](markdown/NCIT_C40181.md) (Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm) [7][53.33%]
1. [NCIT:C40195](markdown/NCIT_C40195.md) (Cervical Squamous Neoplasm) [18][53.33%]
1. [NCIT:C40210](markdown/NCIT_C40210.md) (Cervical Glandular Neoplasm) [20][53.55%]
1. [NCIT:C40216](markdown/NCIT_C40216.md) (Cervical Soft Tissue Neoplasm) [11][62.50%]
1. [NCIT:C40226](markdown/NCIT_C40226.md) (Cervical Mixed Epithelial and Mesenchymal Neoplasm) [6][54.17%]
1. [NCIT:C40242](markdown/NCIT_C40242.md) (Vaginal Squamous Neoplasm) [8][53.85%]
1. [NCIT:C40250](markdown/NCIT_C40250.md) (Vaginal Glandular Neoplasm) [10][55.56%]
1. [NCIT:C40265](markdown/NCIT_C40265.md) (Vaginal Soft Tissue Neoplasm) [7][75.00%]
1. [NCIT:C40283](markdown/NCIT_C40283.md) (Vulvar Squamous Neoplasm) [11][55.56%]
1. [NCIT:C40292](markdown/NCIT_C40292.md) (Vulvar Glandular Neoplasm) [13][60.00%]
1. [NCIT:C40303](markdown/NCIT_C40303.md) (Vulvar Neoplasm of Skin Appendage Origin) [12][62.50%]
1. [NCIT:C40315](markdown/NCIT_C40315.md) (Pilomyxoid Astrocytoma) [2][66.67%]
1. [NCIT:C40316](markdown/NCIT_C40316.md) (Vulvar Soft Tissue Neoplasm) [9][75.00%]
1. [NCIT:C40382](markdown/NCIT_C40382.md) (Breast Adenoma) [5][55.00%]
1. [NCIT:C40389](markdown/NCIT_C40389.md) (Breast Myoepithelial Tumor) [6][55.00%]
1. [NCIT:C40392](markdown/NCIT_C40392.md) (Myoepithelial Tumor) [15][55.56%]
1. [NCIT:C40405](markdown/NCIT_C40405.md) (Breast Fibroepithelial Neoplasm) [10][57.14%]
1. [NCIT:C40407](markdown/NCIT_C40407.md) (Kidney Wilms Tumor) [16][60.00%]
1. [NCIT:C40409](markdown/NCIT_C40409.md) (Salivary Gland Pleomorphic Adenoma) [2][56.25%]
1. [NCIT:C40970](markdown/NCIT_C40970.md) (Angiocentric Immunoproliferative Lesion) [15][53.90%]
1. [NCIT:C41247](markdown/NCIT_C41247.md) (Pancreatic Mucinous-Cystic Neoplasm) [4][53.45%]
1. [NCIT:C41248](markdown/NCIT_C41248.md) (Pancreatic Serous Neoplasm) [6][53.45%]
1. [NCIT:C43284](markdown/NCIT_C43284.md) (Primary Systemic Mastocytosis) [4][53.55%]
1. [NCIT:C43313](markdown/NCIT_C43313.md) (Pilar-Associated Mesenchyme Neoplasm) [5][60.00%]
1. [NCIT:C43324](markdown/NCIT_C43324.md) (Outer Hair Sheath and Infundibulum Neoplasm) [10][54.35%]
1. [NCIT:C43345](markdown/NCIT_C43345.md) (Ductal Eccrine Adenocarcinoma) [2][62.50%]
1. [NCIT:C43527](markdown/NCIT_C43527.md) (Sporadic Gastric Adenocarcinoma) [13][53.55%]
1. [NCIT:C43541](markdown/NCIT_C43541.md) (Pituitary Gland Microadenoma) [2][75.00%]
1. [NCIT:C43542](markdown/NCIT_C43542.md) (Pituitary Gland Macroadenoma) [2][75.00%]
1. [NCIT:C43550](markdown/NCIT_C43550.md) (Appendix Adenoma) [5][57.14%]
1. [NCIT:C43558](markdown/NCIT_C43558.md) (Appendix Mucinous Adenocarcinoma) [4][62.50%]
1. [NCIT:C43584](markdown/NCIT_C43584.md) (Rectosigmoid Adenocarcinoma) [2][70.00%]
1. [NCIT:C43585](markdown/NCIT_C43585.md) (Colorectal Mucinous Adenocarcinoma) [3][58.33%]
1. [NCIT:C43586](markdown/NCIT_C43586.md) (Colorectal Signet Ring Cell Carcinoma) [3][63.09%]
1. [NCIT:C43587](markdown/NCIT_C43587.md) (Colorectal Small Cell Neuroendocrine Carcinoma) [2][57.14%]
1. [NCIT:C43588](markdown/NCIT_C43588.md) (Colorectal Squamous Cell Carcinoma) [3][64.29%]
1. [NCIT:C43589](markdown/NCIT_C43589.md) (Colorectal Adenosquamous Carcinoma) [2][66.67%]
1. [NCIT:C43590](markdown/NCIT_C43590.md) (Colorectal Medullary Carcinoma) [2][62.50%]
1. [NCIT:C43591](markdown/NCIT_C43591.md) (Colorectal Undifferentiated Carcinoma) [2][64.29%]
1. [NCIT:C45194](markdown/NCIT_C45194.md) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type) [2][55.56%]
1. [NCIT:C45332](markdown/NCIT_C45332.md) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype) [2][54.38%]
1. [NCIT:C45540](markdown/NCIT_C45540.md) (Lung Sarcomatoid Carcinoma) [7][53.45%]
1. [NCIT:C45569](markdown/NCIT_C45569.md) (High Grade Lung Neuroendocrine Neoplasm) [6][54.95%]
1. [NCIT:C45612](markdown/NCIT_C45612.md) (Lung Soft Tissue Neoplasm) [11][66.67%]
1. [NCIT:C45625](markdown/NCIT_C45625.md) (Malignant Lung and Pleural Neoplasm) [4][53.55%]
1. [NCIT:C45835](markdown/NCIT_C45835.md) (Pancreatic Neuroendocrine Tumor G2) [5][53.57%]
1. [NCIT:C45837](markdown/NCIT_C45837.md) (Non-Functional Pancreatic Neuroendocrine Tumor) [3][53.25%]
1. [NCIT:C45840](markdown/NCIT_C45840.md) (Functional Pancreatic Neuroendocrine Tumor) [6][54.55%]
1. [NCIT:C45843](markdown/NCIT_C45843.md) (Pancreatic Carcinoma with Mixed Differentiation) [3][58.33%]
1. [NCIT:C45915](markdown/NCIT_C45915.md) (Gonadotropin-Producing Pituitary Gland Adenoma) [2][80.00%]
1. [NCIT:C47857](markdown/NCIT_C47857.md) (Paget Disease of the Breast) [4][60.00%]
1. [NCIT:C48306](markdown/NCIT_C48306.md) (Adrenal Gland Composite Pheochromocytoma) [2][66.67%]
1. [NCIT:C48314](markdown/NCIT_C48314.md) (Benign Paraganglioma) [2][62.50%]
1. [NCIT:C48596](markdown/NCIT_C48596.md) (Invasive Prostate Carcinoma) [19][54.67%]
1. [NCIT:C49166](markdown/NCIT_C49166.md) (Extracardiac Rhabdomyoma) [6][60.19%]
1. [NCIT:C53459](markdown/NCIT_C53459.md) (Chondroma) [6][53.25%]
1. [NCIT:C53684](markdown/NCIT_C53684.md) (Benign Connective and Soft Tissue Neoplasm) [282][61.93%]
1. [NCIT:C53704](markdown/NCIT_C53704.md) (Secondary Osteosarcoma) [2][57.14%]
1. [NCIT:C53972](markdown/NCIT_C53972.md) (Erdheim-Chester Disease) [2][55.00%]
1. [NCIT:C53994](markdown/NCIT_C53994.md) (Undifferentiated Stromal Sarcoma) [4][53.45%]
1. [NCIT:C53999](markdown/NCIT_C53999.md) (Malignant Gastrointestinal Stromal Tumor) [7][57.14%]
1. [NCIT:C61574](markdown/NCIT_C61574.md) (Uterine Corpus Cancer) [34][55.15%]
1. [NCIT:C62282](markdown/NCIT_C62282.md) (Skin Nodular Basal Cell Carcinoma) [2][62.50%]
1. [NCIT:C65151](markdown/NCIT_C65151.md) (Non-Small Cell Carcinoma) [63][57.00%]
1. [NCIT:C65192](markdown/NCIT_C65192.md) (Tubular Adenocarcinoma) [6][53.82%]
1. [NCIT:C66950](markdown/NCIT_C66950.md) (Hepatoid Adenocarcinoma) [4][75.00%]
1. [NCIT:C67155](markdown/NCIT_C67155.md) (Olfactory Neurogenic Tumor) [5][53.33%]
1. [NCIT:C68627](markdown/NCIT_C68627.md) (Childhood Extracranial Germ Cell Tumor) [4][56.25%]
1. [NCIT:C72074](markdown/NCIT_C72074.md) (Atypical Carcinoid Tumor) [3][62.50%]
1. [NCIT:C79951](markdown/NCIT_C79951.md) (Papillary Adenoma) [7][53.35%]
1. [NCIT:C80280](markdown/NCIT_C80280.md) (Diffuse Large B-Cell Lymphoma, Not Otherwise Specified) [24][56.77%]
1. [NCIT:C80291](markdown/NCIT_C80291.md) (High Grade B-Cell Lymphoma, Not Otherwise Specified) [2][60.00%]
1. [NCIT:C80307](markdown/NCIT_C80307.md) (Waldenstrom Macroglobulinemia) [2][60.00%]
1. [NCIT:C80308](markdown/NCIT_C80308.md) (Splenic B-Cell Lymphoma/Leukemia, Unclassifiable) [2][56.25%]
1. [NCIT:C80331](markdown/NCIT_C80331.md) (B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1) [3][53.45%]
1. [NCIT:C80683](markdown/NCIT_C80683.md) (Therapy-Related Leukemia) [4][53.35%]
1. [NCIT:C82179](markdown/NCIT_C82179.md) (Mixed Phenotype Acute Leukemia) [7][55.26%]
1. [NCIT:C82338](markdown/NCIT_C82338.md) (Myeloid Proliferations Related to Down Syndrome) [2][53.57%]
1. [NCIT:C82426](markdown/NCIT_C82426.md) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM) [2][60.00%]
1. [NCIT:C82430](markdown/NCIT_C82430.md) (Acute Myeloid Leukemia with Gene Mutations) [2][57.14%]
1. [NCIT:C82591](markdown/NCIT_C82591.md) (Myelodysplastic Syndrome with Single Lineage Dysplasia) [3][53.33%]
1. [NCIT:C84270](markdown/NCIT_C84270.md) (Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2) [5][53.35%]
1. [NCIT:C87797](markdown/NCIT_C87797.md) (Secondary Central Nervous System Lymphoma) [3][66.67%]
1. [NCIT:C88156](markdown/NCIT_C88156.md) (Leukemia Cutis) [3][57.44%]
1. [NCIT:C88981](markdown/NCIT_C88981.md) (Stage I Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88982](markdown/NCIT_C88982.md) (Stage II Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88983](markdown/NCIT_C88983.md) (Stage III Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88984](markdown/NCIT_C88984.md) (Stage IV Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C89989](markdown/NCIT_C89989.md) (Stage II Colorectal Cancer AJCC v7) [3][62.50%]
1. [NCIT:C89994](markdown/NCIT_C89994.md) (Stage III Colorectal Cancer AJCC v7) [3][62.50%]
1. [NCIT:C89999](markdown/NCIT_C89999.md) (Stage IV Colon Cancer AJCC v7) [2][55.56%]
1. [NCIT:C94540](markdown/NCIT_C94540.md) (Anterior Pituitary Gland Endocrine Neoplasm) [35][56.36%]
1. [NCIT:C95397](markdown/NCIT_C95397.md) (Intramucosal Adenocarcinoma) [3][60.00%]
1. [NCIT:C95404](markdown/NCIT_C95404.md) (Digestive System Neuroendocrine Tumor) [124][57.09%]
1. [NCIT:C95405](markdown/NCIT_C95405.md) (Digestive System Neuroendocrine Carcinoma) [39][55.56%]
1. [NCIT:C95406](markdown/NCIT_C95406.md) (Digestive System Mixed Adenoneuroendocrine Carcinoma) [15][53.57%]
1. [NCIT:C95488](markdown/NCIT_C95488.md) (Non-Invasive Pancreatic Mucinous-Cystic Neoplasm) [2][57.14%]
1. [NCIT:C95505](markdown/NCIT_C95505.md) (Pancreatic Intraductal Neoplasm) [8][54.07%]
1. [NCIT:C95542](markdown/NCIT_C95542.md) (Pancreatic Acinar Cell Neoplasm) [3][53.33%]
1. [NCIT:C95584](markdown/NCIT_C95584.md) (Pancreatic Neuroendocrine Tumor G1) [2][54.71%]
1. [NCIT:C95619](markdown/NCIT_C95619.md) (Esophageal Neuroendocrine Carcinoma) [2][58.33%]
1. [NCIT:C95871](markdown/NCIT_C95871.md) (Gastric Neuroendocrine Tumor) [6][62.50%]
1. [NCIT:C95884](markdown/NCIT_C95884.md) (Gastric Neuroendocrine Carcinoma) [2][63.64%]
1. [NCIT:C95909](markdown/NCIT_C95909.md) (Preinvasive Neoplasm of the Ampullary Region) [8][53.35%]
1. [NCIT:C95913](markdown/NCIT_C95913.md) (Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type) [2][75.00%]
1. [NCIT:C95984](markdown/NCIT_C95984.md) (Ampulla of Vater Neuroendocrine Carcinoma) [2][53.57%]
1. [NCIT:C96061](markdown/NCIT_C96061.md) (Small Intestinal Neuroendocrine Tumor) [14][58.33%]
1. [NCIT:C96062](markdown/NCIT_C96062.md) (Intestinal Neuroendocrine Tumor) [38][54.17%]
1. [NCIT:C96063](markdown/NCIT_C96063.md) (Intestinal Neuroendocrine Carcinoma) [8][57.69%]
1. [NCIT:C96064](markdown/NCIT_C96064.md) (Small Intestinal Neuroendocrine Carcinoma) [2][63.64%]
1. [NCIT:C96156](markdown/NCIT_C96156.md) (Colorectal Neuroendocrine Carcinoma) [4][57.69%]
1. [NCIT:C96159](markdown/NCIT_C96159.md) (Colorectal Neuroendocrine Tumor) [19][55.56%]
1. [NCIT:C96160](markdown/NCIT_C96160.md) (Colorectal Neuroendocrine Tumor G1) [6][56.25%]
1. [NCIT:C96165](markdown/NCIT_C96165.md) (Intestinal Neuroendocrine Tumor G2) [2][66.67%]
1. [NCIT:C96166](markdown/NCIT_C96166.md) (Digestive System Neuroendocrine Tumor G2) [16][53.55%]
1. [NCIT:C96414](markdown/NCIT_C96414.md) (Sessile Serrated Adenoma/Polyp) [4][54.17%]
1. [NCIT:C96422](markdown/NCIT_C96422.md) (Appendix Neuroendocrine Tumor) [12][57.14%]
1. [NCIT:C96425](markdown/NCIT_C96425.md) (Appendix Neuroendocrine Carcinoma) [2][58.33%]
1. [NCIT:C96478](markdown/NCIT_C96478.md) (Colorectal Adenomatous Polyp) [4][53.85%]
1. [NCIT:C96549](markdown/NCIT_C96549.md) (Anal Canal Neuroendocrine Carcinoma) [2][58.33%]
1. [NCIT:C96756](markdown/NCIT_C96756.md) (Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [5][53.35%]
1. [NCIT:C96881](markdown/NCIT_C96881.md) (Gallbladder Mucinous Cystic Neoplasm) [3][62.50%]
1. [NCIT:C96918](markdown/NCIT_C96918.md) (Gallbladder Neuroendocrine Tumor) [3][58.33%]
1. [NCIT:C96919](markdown/NCIT_C96919.md) (Gallbladder Neuroendocrine Carcinoma) [2][56.25%]
1. [NCIT:C96955](markdown/NCIT_C96955.md) (Extrahepatic Bile Duct Neuroendocrine Tumor) [2][60.82%]
1. [NCIT:C96956](markdown/NCIT_C96956.md) (Extrahepatic Bile Duct Neuroendocrine Carcinoma) [2][53.33%]
1. [NCIT:C114750](markdown/NCIT_C114750.md) (Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [2][62.50%]
1. [NCIT:C114782](markdown/NCIT_C114782.md) (Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [2][62.50%]
1. [NCIT:C114801](markdown/NCIT_C114801.md) (Childhood Gonadal Germ Cell Tumor) [3][51.82%]
1. [NCIT:C114940](markdown/NCIT_C114940.md) (Malignant Cardiovascular Neoplasm) [110][56.76%]
1. [NCIT:C121654](markdown/NCIT_C121654.md) (Spindle Cell/Sclerosing Rhabdomyosarcoma) [2][62.50%]
1. [NCIT:C121671](markdown/NCIT_C121671.md) (Angiosarcoma of Soft Tissue) [18][58.33%]
1. [NCIT:C121793](markdown/NCIT_C121793.md) (Undifferentiated/Unclassified Sarcoma) [12][54.15%]
1. [NCIT:C121926](markdown/NCIT_C121926.md) (Intermediate Bone Neoplasm) [4][53.33%]
1. [NCIT:C121974](markdown/NCIT_C121974.md) (Ph-Like Acute Lymphoblastic Leukemia) [2][58.33%]
1. [NCIT:C123329](markdown/NCIT_C123329.md) (Multiple Endocrine Neoplasia Type 2) [2][58.33%]
1. [NCIT:C127194](markdown/NCIT_C127194.md) (Growth Hormone and Prolactin-Producing Adenoma) [2][57.14%]
1. [NCIT:C131610](markdown/NCIT_C131610.md) (Ependymal Tumor of Brain and Spinal Cord) [2][64.05%]
1. [NCIT:C134604](markdown/NCIT_C134604.md) (Intrahepatic Bile Duct Cancer by AJCC v8 Stage) [11][75.00%]
1. [NCIT:C136486](markdown/NCIT_C136486.md) (Lung Adenocarcinoma In Situ) [2][66.67%]
1. [NCIT:C136610](markdown/NCIT_C136610.md) (Bone Cancer by AJCC v7 Stage) [14][66.67%]
1. [NCIT:C136612](markdown/NCIT_C136612.md) (Bone Cancer by AJCC v8 Stage) [4][66.67%]
1. [NCIT:C136694](markdown/NCIT_C136694.md) (Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage) [4][75.00%]
1. [NCIT:C136769](markdown/NCIT_C136769.md) (Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage) [4][60.00%]
1. [NCIT:C138195](markdown/NCIT_C138195.md) (High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements) [2][60.00%]

